TSS:Rfhg 217246.1

Basic information about the TSS

---

TSS ID: rfhg_217246.1 Species: human Chr: chr20		Start: 1937756 End: 1937772 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: U06681:165 GeneID: 140885 HGNC/MGI_ID: HGNC:9662 UniProt_ID: Nearer transcript ids and distances:

Gene_name: PDYN-AS1 Gene_symbol: SIRPA Gene_synonyms: BIT CD172a MFR MYD-1 P84 SHPS-1 SHPS1 SIRP SIRP-ALPHA-1 SIRPalpha SIRPalpha2 Gene_source: HGNC:9662

TATA-Box annotation

---

Distance to TSS:	-9446
Nearest PromoterID:	NR_134520
Entrez ID:	727993
Nearest Unigene:	Hs.551466
Nearest Refseq:	NR_134520
Nearest Ensembl:	ENSG00000233896
Gene Name:	PDYN-AS1
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.823529
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SIRPA p2@SIRPA p3@SIRPA p4@SIRPA p5@SIRPA p6@SIRPA p7@SIRPA p8@SIRPA p9@SIRPA p10@SIRPA
Sample		p1@SIRPA	p2@SIRPA	p3@SIRPA	p4@SIRPA	p5@SIRPA	p6@SIRPA	p7@SIRPA	p8@SIRPA	p9@SIRPA	p10@SIRPA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	0.39	0.39	0.00	0.19	4.29	0.19	1.36	0.00	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	0.81	3.03	0.20	0.20	7.49	1.62	0.61	0.61	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.77	0.96	0.00	0.19	5.98	0.39	1.35	0.19	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	0.83	1.46	0.21	0.21	5.41	0.21	1.25	0.83	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.25	2.25	0.00	1.12	5.85	0.00	1.12	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	0.58	1.55	0.19	0.97	4.85	0.78	1.55	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.31	1.09	0.44	0.22	3.27	0.22	1.53	0.22	0.65	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2.42	2.18	0.00	0.48	4.12	0.73	0.73	0.00	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1.28	2.56	0.00	0.64	4.06	1.28	1.28	0.00	0.00	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	0.00	2.32	0.58	0.00	2.32	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	0.00	1.21	0.00	0.00	2.02	0.40	0.81	0.00	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	0.41	0.41	0.41	0.81	0.81	0.81	2.03	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.19	7.25	0.64	2.58	3.22	0.48	1.13	0.48	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.18	5.11	1.05	1.80	3.01	1.95	0.60	0.75	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.42	4.39	1.10	1.10	2.63	0.66	0.88	0.22	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.30	6.79	0.25	1.51	1.26	0.75	2.01	1.26	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.58	2.84	1.09	2.18	3.28	1.09	1.09	0.00	0.87	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	6.33	0.84	2.95	2.11	0.84	1.27	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	4.27	0.53	1.60	3.73	1.07	1.07	0.00	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.48	4.66	0.90	2.11	1.81	0.75	1.20	0.90	0.00	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.09	6.28	0.53	2.00	1.87	1.34	0.67	0.94	0.27	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.36	6.39	1.21	1.73	3.45	1.73	1.38	1.04	0.69	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.70	5.69	0.90	1.81	1.81	1.42	1.55	1.03	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.16	5.58	0.49	1.94	2.18	0.49	1.94	0.49	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.13	4.90	1.81	2.32	5.93	1.03	1.81	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.34	7.28	0.32	3.48	3.48	1.90	0.95	0.00	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.58	7.69	1.10	2.20	4.40	1.65	1.65	0.55	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.44	10.84	0.94	4.48	4.48	1.65	2.12	1.65	0.24	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.21	7.27	0.65	1.94	5.65	1.45	1.62	0.32	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.30	7.96	0.90	2.53	5.61	0.90	0.90	1.09	0.36	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.26	10.26	0.63	2.30	5.86	2.30	1.26	0.21	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.78	8.40	0.78	3.71	8.21	1.76	2.15	0.98	0.39	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.04	7.81	0.21	1.27	5.49	1.48	2.11	1.06	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.85	2.80	0.16	2.14	3.79	0.00	1.32	0.16	0.49	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.15	11.03	0.93	3.18	5.80	1.50	2.99	1.31	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.14	11.69	1.15	2.11	8.43	1.34	2.30	0.57	0.19	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.55	8.79	1.02	3.47	4.50	1.43	3.07	1.23	0.41	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.10	10.07	0.20	2.42	5.24	2.01	1.81	0.60	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.64	8.10	0.54	4.05	6.75	2.43	2.16	0.54	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.88	6.48	0.96	2.16	4.08	1.44	1.68	0.24	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.35	9.88	0.47	2.59	7.06	0.94	1.65	1.41	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.35	3.81	0.44	2.20	5.12	0.88	0.88	1.02	0.29	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.14	11.18	1.69	4.01	5.91	1.48	3.80	1.27	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.18	10.84	1.57	1.92	7.17	1.22	2.80	0.52	0.17	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.68	11.24	0.80	2.21	3.81	1.20	2.21	2.21	0.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.38	9.07	0.93	3.72	5.12	2.56	2.33	2.79	0.47	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.43	15.59	0.72	3.36	5.04	1.44	3.36	0.72	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.78	12.22	0.60	1.49	4.77	2.98	2.68	1.49	0.89	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.98	13.88	1.44	2.87	7.42	1.20	3.35	0.96	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.85	18.00	2.02	2.22	7.08	3.24	2.22	2.02	0.40	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.51	11.68	0.82	2.66	6.97	1.43	2.25	1.02	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	30.02	18.68	1.56	5.11	7.78	1.78	4.45	1.56	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.97	14.90	1.06	3.19	10.29	3.55	3.90	1.06	0.71	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.50	16.57	0.99	1.99	7.62	1.66	2.32	1.33	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	0.00	4.19	1.68	1.68	0.84	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	5.05	0.92	1.84	3.67	0.92	2.30	0.46	0.92	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	18.80	0.65	4.54	6.48	2.59	2.92	0.32	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.87	25.69	1.28	0.96	5.14	2.57	4.18	0.96	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.06	5.97	0.94	2.20	4.40	2.51	1.26	1.26	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	25.38	0.00	2.82	6.35	1.41	4.94	2.12	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.80	18.51	1.12	2.24	3.36	1.68	5.05	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	9.55	1.59	0.00	3.98	0.80	2.39	0.00	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	24.80	10.19	1.70	1.36	4.42	1.36	1.36	1.36	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	30.87	2.60	2.27	7.47	2.27	2.27	1.95	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.46	22.36	1.77	2.48	6.03	1.42	4.26	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	16.16	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	0.00	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.38	8.78	3.41	0.98	4.88	1.95	1.95	0.00	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.32	5.45	1.98	0.99	2.98	1.49	1.49	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.68	7.97	0.47	1.88	4.69	0.94	1.41	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.27	4.64	1.66	0.33	1.99	1.66	0.00	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.90	8.04	0.31	1.24	0.93	0.62	0.00	1.24	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.84	6.42	0.61	0.31	0.61	0.92	0.31	0.61	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	20.27	4.28	0.95	3.33	2.22	0.95	1.90	1.58	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	10.27	4.97	1.44	1.44	1.60	1.28	1.28	0.96	2.09	0.00
Adipocyte - omental, donor1	11473-119C6	36.51	7.76	3.56	3.69	4.96	1.27	2.29	2.29	2.67	0.25
Adipocyte - omental, donor2	11474-119C7	18.69	7.47	0.00	2.99	2.99	2.99	2.24	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	12.06	8.71	2.01	2.01	3.01	2.01	1.34	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	24.24	5.10	0.64	5.10	4.47	1.91	1.28	3.83	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	1.10	0.00	1.10	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	1.81	0.00	1.35	1.35	0.90	0.90	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.00	3.30	0.35	3.13	1.04	1.22	0.00	0.35	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	65.13	26.99	3.13	6.06	8.80	1.17	1.56	3.52	1.17	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	85.96	28.31	4.89	5.66	10.04	1.54	2.32	2.06	1.54	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	39.03	21.74	1.12	4.46	4.46	0.56	0.84	1.39	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	46.44	19.99	2.35	5.29	4.11	1.18	1.18	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	17.45	7.16	4.75	2.33	1.93	0.80	0.72	2.17	0.40	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	50.67	20.33	5.81	3.23	5.49	1.61	2.26	1.61	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	20.26	7.46	0.53	1.60	3.73	1.07	0.00	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	6.68	1.11	6.12	2.23	1.11	1.11	0.00	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	1.66	0.83	2.08	0.83	1.66	1.25	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.89	15.32	5.78	0.75	4.02	0.75	0.50	1.51	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	8.84	6.87	1.96	2.95	4.25	0.00	1.31	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.70	3.35	2.74	1.52	2.44	0.61	0.61	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	28.73	7.96	0.66	0.88	2.87	1.55	2.65	0.88	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.74	2.51	0.00	0.00	0.00	0.72	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	1.20	0.00	1.20	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	1.26	2.16	0.00	0.00	1.08	0.36	1.98	0.18	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	3.35	0.00	0.00	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.08	4.93	0.82	0.41	1.23	0.62	2.05	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	3.09	1.83	0.80	0.80	1.03	0.34	0.57	0.80	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	2.69	4.90	0.24	0.73	0.98	1.22	0.24	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.32	7.64	0.45	0.45	4.04	0.90	1.35	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.10	6.08	2.17	2.17	2.17	0.87	0.87	0.43	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	4.28	0.00	0.00	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.01	10.46	1.49	1.20	1.49	0.60	0.60	1.20	0.60	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	5.06	1.26	0.00	3.79	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	4.62	2.64	1.32	1.98	3.30	0.00	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.54	5.52	2.92	0.32	2.27	1.62	0.00	0.65	1.30	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.99	6.31	0.97	0.49	0.00	0.49	2.43	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	4.75	1.19	2.97	2.38	0.00	1.78	1.78	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.33	9.79	2.26	0.75	4.14	1.51	0.00	0.38	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	7.26	1.45	0.00	1.45	0.73	0.73	0.00	2.18	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	7.52	0.00	0.00	0.00	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.94	5.93	1.32	0.66	1.48	2.14	1.48	0.99	0.16	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	5.46	2.73	0.00	2.73	1.36	0.00	0.00	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.74	6.03	1.36	0.90	1.21	1.66	0.75	0.60	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	22.50	6.97	1.07	0.54	2.14	1.07	1.07	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	19.27	8.88	2.08	0.94	2.08	1.32	1.32	0.94	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	23.25	7.48	2.67	2.67	2.14	1.60	1.07	0.53	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	3.90	0.00	0.98	1.95	1.95	7.80	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.76	7.30	1.49	0.83	1.66	0.66	1.49	0.66	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	20.41	4.80	1.20	0.00	2.40	0.00	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	14.16	0.00	0.00	0.00	3.54	3.54	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.04	7.72	1.03	0.34	2.74	0.69	0.69	0.86	1.20	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.53	5.83	0.97	0.97	2.91	0.97	1.46	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.80	5.69	1.52	1.14	1.90	0.76	0.76	1.14	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	3.63	1.21	1.21	1.21	0.00	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	8.55	0.57	1.14	2.28	1.14	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.67	7.27	2.14	0.86	1.92	0.43	1.07	0.43	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.78	6.19	0.26	0.52	2.06	1.03	1.03	0.77	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	6.57	1.88	0.47	0.94	0.00	2.35	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.76	6.75	0.64	1.93	1.29	1.29	0.96	0.32	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	4.28	0.71	0.71	2.85	2.14	0.00	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	7.60	0.58	1.75	2.34	0.58	1.17	1.17	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.68	11.74	2.41	1.20	0.90	0.90	1.51	0.30	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	4.75	3.56	1.19	2.38	2.38	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	5.59	0.00	1.02	2.54	2.03	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.75	7.39	2.04	0.51	0.76	1.02	1.53	1.27	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	5.08	1.91	0.00	1.91	0.00	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.10	6.04	0.43	0.43	1.73	0.86	0.86	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.45	7.83	1.69	1.06	1.06	1.06	0.21	0.21	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.11	5.22	1.74	0.29	0.58	2.03	1.16	0.29	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	9.45	1.89	2.83	0.00	0.00	0.00	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.27	7.46	1.02	0.68	1.19	1.02	0.51	0.17	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	4.63	0.00	0.00	0.00	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	4.23	6.34	0.00	0.00	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	21.01	9.22	2.14	0.64	2.14	1.72	0.86	0.21	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	7.82	0.60	1.20	3.61	0.00	1.20	1.20	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	5.83	0.00	0.00	2.92	1.46	0.73	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.39	6.90	2.07	0.46	1.38	0.92	2.07	1.38	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	5.10	2.55	0.00	5.10	2.55	5.10	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.10	6.86	1.78	0.25	1.27	1.78	1.27	0.25	0.00	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.23	8.05	1.86	1.24	2.48	1.65	0.62	1.03	1.65	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.42	7.96	1.84	0.92	1.22	1.22	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	7.17	0.96	1.43	2.87	0.96	0.48	0.00	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.51	7.98	0.89	1.33	3.33	2.66	0.44	0.44	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	0.00	3.05	3.05	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	3.32	4.43	0.55	1.66	0.55	2.77	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.07	8.74	1.32	1.06	1.85	1.06	0.53	0.53	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.99	5.82	1.45	0.36	0.73	1.82	2.18	1.09	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.88	4.91	0.25	1.72	2.58	0.49	1.60	0.12	0.61	0.37
Astrocyte - cerebellum, donor2	11580-120F5	7.70	5.31	0.34	1.71	1.03	0.86	1.03	0.34	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.89	1.68	0.42	0.63	1.47	0.42	0.21	0.21	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	7.67	4.53	0.00	3.14	3.83	0.70	1.05	0.70	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	13.91	7.60	0.16	2.59	6.15	0.81	1.62	0.65	0.65	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	7.91	6.71	0.60	1.94	2.09	0.60	1.49	0.60	0.30	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.36	4.01	2.29	0.34	2.75	1.49	0.92	0.11	1.26	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	6.26	5.14	2.76	0.25	3.76	2.13	0.63	0.13	1.25	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	4.67	4.44	1.37	0.23	3.19	2.62	0.80	0.00	1.25	1.02
Basophils, donor1	12241-129G9	29.81	3.66	2.88	0.78	0.52	1.57	3.14	3.14	0.00	0.26
Basophils, donor2	12242-129H1	31.03	2.89	2.89	0.36	1.44	1.08	1.44	4.33	0.36	0.00
Basophils, donor3	12243-129H2	37.04	9.26	7.79	0.44	1.62	2.35	4.85	8.53	0.44	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	14.23	4.96	0.86	0.65	2.16	1.94	4.31	0.65	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	39.32	12.34	3.20	0.91	4.57	5.94	2.74	0.91	2.74	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	8.16	3.77	0.63	0.63	0.00	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	24.95	11.23	1.25	1.66	1.46	1.46	3.74	2.29	0.21	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	5.53	0.00	1.38	1.61	2.07	1.15	0.46	0.23	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	5.76	3.24	0.90	0.72	2.16	0.90	1.98	0.00	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.04	2.24	3.20	0.96	0.64	0.32	2.24	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	10.34	0.00	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	74.39	5.07	5.07	1.69	5.07	1.13	13.53	20.29	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	127.88	16.89	11.88	2.97	8.17	4.64	12.44	21.34	3.53	0.93
CD14+ Monocytes, donor3	11381-118B4	77.50	18.00	3.73	0.22	6.59	3.95	12.07	14.71	1.54	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	65.67	49.82	12.17	5.66	6.51	7.36	4.81	8.49	1.42	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.65	61.79	30.33	4.93	7.96	7.58	7.58	10.24	5.31	4.55
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	68.38	61.47	32.55	4.93	6.25	5.26	4.60	12.49	2.63	2.96
CD14+ monocytes - mock treated, donor1	11863-125A9	56.52	13.44	18.21	1.45	3.04	1.30	4.91	12.43	6.22	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	13.58	9.66	1.21	3.92	3.02	4.53	10.56	2.72	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	55.43	14.45	13.50	1.42	3.79	1.90	4.26	12.56	1.90	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	97.09	20.59	26.95	2.18	5.19	1.67	7.37	18.75	6.19	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	87.22	17.94	15.73	1.38	4.97	1.66	3.86	11.32	1.10	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	109.09	18.59	25.04	1.49	6.45	3.72	7.19	9.42	2.73	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	56.59	13.71	23.30	1.17	3.52	1.96	3.92	6.85	3.72	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	40.95	8.90	14.07	0.71	2.67	0.89	3.92	7.30	1.60	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	54.19	8.92	16.32	0.22	3.26	1.96	3.26	5.44	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	109.34	17.33	19.90	1.64	7.26	3.04	5.62	11.71	2.34	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	118.81	10.56	15.31	1.06	6.86	1.58	5.28	9.50	0.53	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	148.65	17.75	26.62	1.11	11.09	2.22	4.44	19.97	4.44	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	69.32	14.58	19.04	1.93	3.27	1.64	5.50	15.17	5.21	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	58.27	9.78	10.78	0.60	3.39	2.00	3.39	6.59	2.59	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	54.34	9.16	18.74	0.42	2.50	1.87	0.83	6.45	1.67	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	128.35	17.16	23.79	2.06	4.58	1.60	6.41	16.93	7.09	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	80.53	5.88	14.70	0.90	3.39	1.81	4.98	9.95	0.90	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	92.97	15.71	20.95	0.87	5.67	3.06	5.24	10.91	3.06	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	8.34	10.22	0.54	2.96	2.96	4.03	9.41	2.42	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.54	8.37	8.03	0.52	0.70	2.62	4.01	7.85	1.74	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.87	10.52	13.89	0.84	2.10	2.10	4.63	4.63	2.10	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	151.38	16.17	28.48	1.84	2.94	2.39	7.53	12.86	5.88	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	155.70	20.43	22.90	1.41	4.23	2.82	4.58	14.80	2.47	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	181.19	26.32	41.68	0.88	6.14	2.19	9.65	13.60	4.83	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	46.38	8.02	18.48	0.87	4.01	1.05	2.62	5.93	2.09	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.45	6.32	8.92	0.00	4.09	0.74	1.49	2.97	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	39.66	7.54	14.01	0.86	4.53	2.80	3.88	5.82	0.86	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	125.71	15.15	26.62	2.05	3.69	1.23	4.91	10.65	4.91	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	102.69	8.58	17.38	0.93	3.71	2.09	6.72	6.72	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	120.64	12.99	29.00	1.16	2.78	1.16	5.80	16.94	1.39	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	5.67	3.27	3.92	0.22	0.87	0.65	1.53	3.71	0.65	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	7.16	3.93	4.16	0.23	1.85	2.08	3.46	3.23	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	4.55	4.12	4.12	0.00	0.65	1.08	1.08	3.90	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	39.86	13.08	22.11	1.25	3.43	4.05	3.89	17.29	1.40	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	38.95	15.54	12.40	0.35	2.10	3.32	2.97	9.61	1.05	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	34.11	13.60	20.29	0.67	3.57	3.79	6.02	8.70	2.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	0.26	0.51	2.55	0.00	0.51	1.02	0.00	1.28	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.66	0.22	1.98	0.00	0.44	0.22	0.00	1.32	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.21	0.42	1.26	0.00	0.00	0.21	0.00	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	1.36	1.36	0.00	0.00	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	2.67	0.00	2.13	0.53	0.53	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.54	0.00	1.07	0.00	0.00	0.00	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	1.40	0.00	0.00	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.78	1.57	0.78	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	0.00	0.00	0.00	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.80	0.00	0.00	0.73	0.00	0.73	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.50	0.00	0.50	0.00	0.00	1.01	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	0.00	0.00	0.00	0.81	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	0.80	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	1.00	0.00	3.01	0.00	0.00	1.00	0.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	23.03	1.69	1.12	1.12	1.12	0.56	1.12	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4.88	3.38	5.64	0.38	0.38	1.13	0.38	0.00	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5.19	4.96	6.54	0.68	0.90	0.23	0.23	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	1.22	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.61	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	0.00	0.51	0.00	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.99	0.00	0.49	0.00	0.00	0.00	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.83	0.83	1.38	0.00	0.00	0.28	0.55	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.25	0.25	0.25	0.00	0.00	0.00	0.25	0.25	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	3.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.51	0.36	1.79	0.36	0.00	0.72	0.00	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.06	0.92	0.00	0.00	3.21	2.98	0.92	0.23	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.24	0.48	0.00	0.00	3.12	0.48	1.44	0.24	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.00	1.09	0.00	0.00	2.46	0.27	0.55	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.00	0.60	0.00	0.30	4.80	0.90	0.90	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.72	1.20	0.00	0.24	2.40	2.16	1.20	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.68	0.91	0.00	0.00	3.41	0.68	0.68	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.00	0.43	0.00	0.22	3.48	0.43	0.43	0.43	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.53	0.53	0.00	0.00	3.16	1.58	0.53	0.26	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.70	0.94	0.00	0.23	3.75	0.94	0.47	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.30	1.81	0.00	0.00	2.72	0.30	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.87	0.87	0.00	0.00	1.74	0.87	0.58	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.00	0.80	0.00	0.00	2.13	0.80	0.80	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.44	2.19	0.00	0.00	3.06	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.82	1.37	0.00	0.46	4.55	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.00	1.49	0.00	0.00	2.24	0.00	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	0.00	0.00	0.36	4.32	1.08	0.72	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.58	0.86	0.00	0.00	3.45	0.86	0.58	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.47	0.47	0.00	0.24	4.01	0.47	0.71	0.24	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.32	1.27	0.00	0.00	4.12	0.95	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.92	0.92	0.00	0.00	3.38	1.23	0.92	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.64	0.64	0.00	0.32	2.89	1.28	0.96	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.38	1.15	0.00	0.00	2.29	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.39	0.79	0.00	0.00	3.94	1.58	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	0.00	0.00	0.00	0.76	1.51	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1.61	0.00	0.00	0.00	1.61	3.21	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2.10	2.80	0.00	0.00	2.10	2.10	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1.00	5.01	0.00	0.00	6.01	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	1.83	0.00	1.83	1.83	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.89	5.43	0.99	0.99	1.48	0.99	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	5.26	3.89	0.63	0.74	1.37	0.53	0.53	0.32	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	41.95	15.95	0.69	4.51	8.32	2.43	2.43	1.39	1.73	0.69
Chondrocyte - de diff, donor2	11338-117F6	41.22	7.82	0.00	6.75	6.75	2.13	3.91	1.78	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	44.72	9.67	1.71	7.62	6.14	1.71	2.96	2.96	3.64	0.57
Chondrocyte - re diff, donor2	11339-117F7	92.21	18.80	1.79	3.58	2.69	3.58	0.90	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	77.65	17.39	3.24	3.24	8.49	4.04	1.21	4.45	0.40	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	2.52	0.69	0.46	1.03	0.92	0.23	0.23	0.11	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	1.50	1.50	0.21	0.00	2.35	1.07	0.21	0.43	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	2.21	1.33	0.09	0.44	1.50	0.35	0.27	0.44	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.94	6.60	14.03	10.36	6.05	4.40	3.12	1.38	2.02	1.28
Corneal Epithelial Cells, donor1	11526-119I5	7.25	3.07	0.66	1.10	0.66	2.42	4.17	1.10	0.44	0.44
Corneal Epithelial Cells, donor2	11606-120I4	6.83	2.28	0.00	1.14	1.14	0.00	7.96	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.41	2.81	0.26	0.51	1.28	1.02	4.86	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	18.49	11.72	15.02	0.83	15.85	7.43	6.77	14.36	0.66	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.98	10.09	20.50	0.63	22.39	10.41	7.25	13.56	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	10.35	6.90	0.00	17.25	3.45	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.12	11.66	5.83	0.32	17.82	7.56	4.32	8.42	3.02	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.47	1.37	1.02	0.34	1.37	0.34	0.34	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.92	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.97	0.00	0.48	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	10.67	9.84	1.00	0.17	1.33	0.33	1.00	0.50	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	5.87	0.59	0.00	0.59	1.17	0.59	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	31.11	26.02	2.26	0.57	1.70	1.41	2.83	1.13	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	7.08	0.39	0.79	1.18	1.18	0.39	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.02	13.67	1.16	0.00	1.45	1.16	0.58	0.87	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	9.88	12.94	0.47	0.24	1.18	0.47	0.71	0.94	0.24	0.71
Endothelial Cells - Artery, donor3	11413-118E9	13.32	10.17	1.40	0.35	1.40	1.75	1.05	0.70	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.75	7.31	0.22	0.66	0.89	1.33	0.22	0.22	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.30	7.30	0.30	0.00	1.52	0.91	2.13	0.61	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	16.63	6.48	0.28	0.28	2.26	0.85	0.56	0.85	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	64.48	34.47	2.97	0.89	9.51	0.59	2.97	2.08	2.38	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	43.74	15.62	2.08	0.00	1.56	0.52	3.12	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	48.92	33.04	3.12	0.71	7.51	1.70	3.12	1.42	2.13	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	13.60	9.60	2.00	0.40	2.00	0.40	1.20	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	11.01	1.05	0.00	0.00	2.10	1.05	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	8.70	8.57	0.99	0.00	1.12	0.87	2.24	0.50	1.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.47	11.08	0.43	0.22	1.09	0.00	0.87	0.00	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.24	18.44	1.47	0.24	0.98	0.85	0.98	0.85	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	9.10	1.14	0.00	0.00	1.14	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	13.97	5.59	1.40	0.00	0.70	0.00	1.40	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.95	8.48	0.47	0.16	1.41	0.79	1.10	0.63	0.16	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	247.54	26.40	26.40	3.30	9.90	21.45	77.56	84.16	0.00	1.65
Eosinophils, donor3	12246-129H5	231.84	39.24	49.94	0.00	24.97	24.97	39.24	85.60	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.26	5.13	0.73	0.24	2.44	2.20	2.93	0.73	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	2.08	10.40	2.08	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.53	11.49	0.41	0.00	9.44	2.46	2.05	1.64	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.81	4.71	0.44	0.99	1.09	1.31	2.19	0.66	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.17	3.47	0.22	0.11	0.22	0.33	0.33	0.54	0.65	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.04	4.61	0.36	1.09	3.03	0.24	1.21	0.61	0.97	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.97	3.68	1.09	2.05	2.87	2.59	1.50	0.55	0.82	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.46	7.70	1.37	2.21	3.38	1.58	1.58	0.74	2.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.67	3.43	0.53	4.22	5.27	3.43	1.05	1.32	1.32	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.30	6.64	1.66	1.33	1.99	1.00	0.33	1.33	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	16.33	9.98	2.72	3.18	5.90	1.36	0.45	0.45	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.22	8.34	2.27	2.27	0.76	2.27	1.52	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	7.25	0.47	1.58	3.79	1.73	1.26	0.95	1.58	0.32
Fibroblast - Cardiac, donor4	11452-119A3	7.88	4.85	0.30	2.42	0.91	0.91	0.91	0.91	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	7.61	5.20	0.25	0.89	1.02	0.89	1.40	0.89	0.76	0.13
Fibroblast - Cardiac, donor6	11460-119B2	6.06	4.40	0.15	0.61	0.91	0.91	0.61	0.61	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	0.40	1.47	0.27	0.13	0.13	0.40	0.00	0.00	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	0.00	0.00	0.00	0.00	0.86	0.00	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	11.72	0.00	0.00	1.46	0.00	0.00	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.99	2.77	0.00	1.38	0.46	0.92	0.69	0.00	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	4.75	2.71	0.68	4.24	1.36	0.51	0.34	0.00	1.02	0.17
Fibroblast - Dermal, donor1	11269-116G9	0.47	0.23	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.19	0.94	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.38	0.97	0.00	0.24	0.24	1.33	0.00	0.24	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	6.78	3.96	0.11	0.34	0.23	0.34	0.34	0.00	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	9.07	2.62	0.00	0.52	0.87	0.70	0.17	0.17	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	9.42	4.71	0.32	0.49	1.14	0.32	0.16	0.00	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	0.83	0.21	0.21	0.00	0.21	0.21	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	9.17	6.03	1.05	0.52	2.10	0.79	0.79	0.52	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	6.59	2.37	0.26	0.66	0.79	0.13	0.40	0.13	0.79	0.26
Fibroblast - Gingival, donor3	11394-118C8	3.29	2.22	0.00	0.77	0.29	0.58	0.48	0.29	0.39	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	6.23	4.16	1.04	1.04	1.04	1.04	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	7.40	6.87	1.41	0.35	2.11	0.53	0.70	0.35	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.56	6.08	0.94	2.18	1.40	1.09	0.78	1.09	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	4.46	2.43	0.54	0.41	0.81	0.27	0.54	0.14	0.81	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	11.29	11.29	2.12	0.71	2.12	0.00	2.47	0.35	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	4.53	2.63	1.02	0.29	0.44	0.29	0.44	0.00	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	5.73	2.45	1.36	0.55	1.09	0.82	0.82	0.41	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	5.81	4.94	0.33	1.10	1.43	0.66	0.88	0.11	0.11	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	4.70	3.08	0.29	1.47	1.03	0.88	0.73	0.15	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	6.80	4.08	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	5.97	0.00	0.00	1.49	0.00	0.00	1.49	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	5.70	4.85	0.63	0.42	1.48	0.84	0.42	0.00	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	11.66	0.83	0.00	3.33	4.17	0.00	0.83	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	4.20	0.00	2.80	1.40	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	6.16	0.28	0.84	0.28	0.84	0.56	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	16.24	8.93	0.81	0.81	2.84	2.44	0.41	2.03	2.44	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	11.98	0.00	3.99	3.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.79	1.16	0.58	0.39	0.39	0.19	0.58	0.00	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.83	4.25	0.30	0.76	0.61	1.06	0.76	0.46	1.06	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1.84	1.53	0.00	0.00	0.00	0.31	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.83	7.25	0.76	1.91	1.91	1.14	0.38	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.10	4.32	1.08	1.08	0.54	0.27	0.54	1.08	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	25.98	11.83	1.51	2.32	4.18	2.67	2.20	2.09	0.70	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	6.96	2.21	0.22	0.22	0.88	0.11	0.77	0.44	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.88	4.88	0.20	0.20	1.83	0.61	0.41	0.81	0.41	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	4.01	0.67	0.00	0.00	0.00	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1.98	1.58	0.00	0.40	0.79	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	34.73	4.37	2.38	5.95	5.95	1.59	1.39	0.00	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.55	5.68	1.07	1.60	1.78	2.13	1.95	0.36	0.89	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	35.08	8.87	2.37	4.93	8.08	3.15	2.17	0.39	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	77.02	9.93	4.51	6.92	10.53	5.42	3.61	0.30	1.50	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.60	7.88	1.94	2.37	4.21	3.99	1.51	0.86	2.59	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.26	7.09	2.78	3.29	4.30	3.29	0.76	1.77	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	23.63	9.68	0.98	2.79	3.61	2.13	2.46	1.97	1.31	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	103.26	9.82	2.41	6.22	10.43	3.61	2.21	1.00	3.41	0.20
Fibroblast - skin normal, donor2	11561-120D4	33.35	8.94	3.82	3.62	4.12	1.31	0.40	0.60	2.51	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.66	6.04	2.42	3.63	3.02	3.32	0.30	0.60	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.53	7.54	1.99	2.57	3.48	2.90	2.07	1.16	1.08	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.14	9.23	1.88	3.08	2.39	2.39	1.03	0.34	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	71.60	9.52	2.96	4.27	8.21	3.28	1.31	0.99	3.28	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.59	10.01	1.92	2.02	2.77	2.24	1.81	0.53	2.02	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	25.64	9.78	2.02	1.35	1.69	0.84	1.35	1.01	0.67	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.80	2.20	2.20	1.57	2.20	0.78	1.57	0.47	1.57	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	22.16	0.00	0.00	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	6.97	0.87	0.87	2.61	0.87	16.56	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.06	9.36	1.04	0.52	3.12	1.56	5.20	0.87	0.35	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	26.54	9.37	1.30	0.26	3.38	1.30	2.34	0.78	1.04	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	22.74	11.75	0.00	0.00	2.56	1.02	5.11	1.28	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	0.00	0.00	0.00	0.00	2.30	2.30	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.91	0.64	0.00	1.28	1.28	0.64	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1.43	0.86	0.00	0.00	0.00	0.00	0.86	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	2.21	1.93	0.00	1.10	3.31	0.83	1.65	0.00	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	35.39	1.37	0.00	0.91	3.20	0.46	0.91	0.00	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.37	2.38	0.20	0.20	1.19	0.20	0.40	0.20	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	4.23	1.85	0.26	1.32	3.17	0.00	0.53	0.26	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	3.91	4.24	1.30	0.98	2.61	0.65	1.63	0.00	0.00	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	0.44	1.33	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1.41	2.12	0.42	0.00	0.71	0.71	0.42	0.14	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	2.46	2.96	0.49	0.25	1.35	0.12	0.37	0.00	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1.34	2.69	0.27	0.27	1.34	0.27	0.27	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.95	2.85	0.74	0.12	2.73	0.62	0.12	0.25	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	4.57	2.49	0.00	0.14	1.80	0.28	0.14	0.00	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	3.25	2.44	0.61	0.00	1.63	0.00	0.20	0.41	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	4.56	3.65	0.91	0.68	1.37	0.23	0.91	0.68	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.85	3.36	0.62	0.25	1.37	0.25	0.25	0.00	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.87	4.59	0.22	0.66	1.75	0.44	0.22	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	1.77	2.66	0.00	0.89	2.36	1.48	0.89	0.00	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	3.18	1.91	0.79	0.00	0.64	0.32	0.95	0.32	0.64	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	2.68	1.79	0.45	0.45	2.90	0.67	0.89	0.89	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	3.23	4.03	1.01	0.20	1.61	0.60	1.01	0.60	0.60	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	4.24	2.71	0.68	0.17	2.21	0.17	0.34	0.00	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	3.72	3.64	0.71	0.80	2.48	0.35	0.71	0.18	0.35	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.80	7.60	3.75	1.35	3.85	0.62	1.04	0.31	1.04	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.17	5.81	2.56	1.37	3.59	0.51	0.51	0.34	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	5.09	6.86	1.22	0.55	2.77	0.55	0.89	0.55	0.77	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.33	4.33	1.58	0.42	2.16	0.42	1.08	0.83	0.17	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4.90	4.70	1.23	0.20	3.27	0.41	0.82	1.23	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4.13	4.33	1.24	1.24	1.65	0.00	0.83	0.00	0.83	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.30	5.42	2.31	0.35	2.42	0.46	0.69	0.23	0.46	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.50	8.51	1.83	1.67	3.67	0.50	1.17	0.67	1.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.16	5.73	3.75	0.44	1.54	0.00	0.88	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	7.13	5.90	2.83	1.35	2.46	0.25	0.74	0.37	1.60	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.10	8.10	2.92	1.13	2.27	0.49	1.30	0.65	1.30	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	8.34	4.49	2.89	2.89	2.57	0.32	0.64	0.32	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.33	6.35	1.80	1.99	2.84	0.57	0.47	0.47	0.47	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.65	9.33	3.48	0.95	3.48	0.63	1.11	0.95	1.11	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	6.69	3.04	1.52	2.74	0.61	0.30	0.00	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.24	5.96	1.36	1.05	3.24	0.52	0.94	0.73	0.94	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.64	13.61	3.29	1.54	5.93	0.88	1.10	0.22	2.20	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.38	5.89	2.24	1.40	1.12	1.12	1.40	0.28	1.12	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.20	15.37	3.52	1.20	4.07	0.83	1.30	1.11	0.37	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.51	15.51	4.28	2.67	6.15	0.53	0.80	0.80	4.28	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.20	10.40	4.13	1.22	4.44	0.92	1.22	1.53	1.68	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.36	10.10	2.46	1.55	2.85	0.26	0.91	0.52	1.30	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.50	26.29	6.78	3.80	7.59	1.08	2.98	1.36	4.34	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.85	10.69	2.77	1.47	3.87	1.47	1.11	0.37	2.95	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.50	8.33	5.26	2.85	3.51	0.88	1.54	0.44	1.32	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	36.69	64.46	9.92	8.93	23.80	1.98	2.98	2.98	4.96	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.89	7.65	3.83	1.19	2.24	0.66	0.40	0.26	2.64	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	10.89	6.05	1.61	1.21	4.44	0.00	0.81	0.40	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	71.42	44.48	19.06	21.35	22.11	5.34	10.42	6.35	7.62	7.12
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.19	1.99	0.20	0.40	0.60	0.40	0.00	0.00	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1.85	1.85	0.31	0.15	1.39	0.46	0.92	0.15	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.43	2.25	0.00	0.20	0.20	0.61	0.41	0.41	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.25	2.19	0.31	0.31	0.63	0.31	0.63	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.28	0.28	0.00	0.28	0.57	0.28	0.57	0.28	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1.84	4.61	0.00	0.00	0.00	0.46	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	4.95	0.00	0.00	0.00	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1.16	2.32	0.00	0.77	1.16	0.00	0.77	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	0.00	1.60	0.00	0.00	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	0.00	6.96	1.74	3.48	0.00	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	0.98	1.95	0.65	0.00	1.30	0.00	0.98	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1.65	1.65	0.00	0.41	0.41	0.00	0.41	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	6.66	0.00	0.00	3.33	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	0.28	0.84	0.28	0.00	1.12	0.00	0.56	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	0.33	1.63	0.33	0.00	1.63	0.00	0.65	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	0.00	2.52	0.00	0.84	2.52	0.84	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	0.32	3.18	0.00	0.32	1.59	0.00	0.64	0.32	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	0.34	0.34	0.00	0.68	1.36	0.00	0.68	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	6.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	0.00	0.57	0.57	0.00	0.57	0.00	0.57	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	0.30	0.59	0.00	0.59	0.59	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	0.00	3.39	0.00	0.00	3.39	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	0.83	1.24	0.41	0.00	0.41	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	0.69	2.99	0.00	0.92	1.61	0.00	1.61	0.69	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	0.38	0.77	0.38	0.00	1.15	0.38	1.15	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	0.00	0.65	0.00	0.00	0.65	0.00	0.33	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	0.00	4.01	0.00	0.00	0.00	0.67	0.00	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	0.39	1.93	0.39	0.00	2.31	1.16	0.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	0.34	1.71	0.68	0.68	2.05	0.34	0.68	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	0.47	1.89	0.47	0.47	2.36	0.00	0.47	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1.21	2.41	0.60	0.00	1.81	0.60	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1.53	3.05	0.51	1.53	2.03	0.00	0.00	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1.20	2.79	0.40	0.80	2.39	0.00	0.40	0.00	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1.48	5.43	0.00	0.49	0.49	0.49	0.99	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	0.00	2.36	0.00	0.00	2.36	0.00	0.00	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	0.58	4.08	0.00	1.17	2.33	0.00	0.00	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.76	1.76	0.00	0.00	1.32	0.44	0.44	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	2.54	1.70	0.00	0.85	1.70	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1.79	2.98	1.79	1.19	2.98	0.00	1.79	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	0.49	2.43	0.49	0.49	1.46	0.00	0.00	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	2.28	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.47	7.48	0.42	0.42	3.33	1.25	1.66	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	4.50	0.00	0.00	1.12	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.81	1.59	0.00	0.95	0.32	0.95	0.95	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	1.25	0.00	0.84	0.84	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.23	0.35	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.17	0.17	0.00	0.17	0.17	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.33	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.12	0.00	0.00	0.00	0.12	0.00	0.00	0.12	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.17	0.17	0.00	0.00	0.00	0.00	0.34	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	7.83	1.12	0.00	2.24	1.68	0.56	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.01	11.25	0.43	0.87	0.87	0.87	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.05	10.93	0.35	2.12	6.00	2.47	1.06	0.35	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.98	7.27	0.73	0.73	7.27	1.45	0.00	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.29	2.80	0.52	0.87	1.22	0.35	0.70	0.87	0.35	0.17
Hepatocyte, donor1	11523-119I2	2.42	8.47	0.00	1.21	1.21	1.21	7.26	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	5.39	15.08	1.08	3.23	7.54	1.08	3.23	2.15	1.08	3.23
Hepatocyte, donor3	11684-122I1	4.29	14.72	0.00	1.23	3.07	3.07	4.91	4.29	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	2.80	2.80	0.00	0.17	1.75	0.52	1.22	1.57	1.57	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	1.10	1.51	0.00	0.27	0.14	0.14	0.41	0.00	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.48	4.41	0.98	0.41	1.63	0.98	3.75	0.33	2.20	0.49
Keratinocyte - epidermal, donor2	11349-117G8	3.51	1.76	0.00	0.59	0.59	1.76	1.76	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	13.44	4.35	0.57	0.00	0.85	1.23	1.99	0.09	0.76	0.09
Keratinocyte - oral, donor1	11251-116E9	19.41	4.99	2.04	0.57	2.38	2.27	3.06	0.00	1.36	1.14
Keratocytes, donor1	11527-119I6	11.00	7.22	0.69	0.34	3.09	1.72	3.78	0.34	0.34	0.34
Keratocytes, donor2	11607-120I5	5.86	4.69	0.00	0.00	1.17	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	6.13	2.37	0.00	0.40	1.38	0.40	0.99	0.20	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	13.19	0.00	0.00	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	3.24	3.24	0.00	1.08	0.00	1.08	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	2.54	1.15	0.12	1.27	0.92	0.00	0.35	0.12	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	2.02	1.41	0.10	0.40	0.50	0.20	0.30	0.30	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	89.29	28.10	2.73	0.95	7.35	1.54	4.03	3.32	4.39	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	50.51	19.26	1.12	1.40	3.63	0.28	1.40	3.07	1.67	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	81.07	31.64	3.78	2.36	7.08	0.63	5.51	3.94	4.41	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	60.22	21.51	1.61	1.61	8.07	0.54	2.69	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	77.53	23.95	4.41	0.63	4.73	0.95	1.26	3.78	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	66.74	25.12	2.26	0.97	4.53	0.86	3.88	3.34	4.31	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	69.77	19.29	2.05	0.82	7.39	0.41	2.87	0.82	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	70.79	18.71	2.28	1.26	4.05	0.76	2.02	1.52	3.79	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	83.04	25.62	4.64	1.83	5.63	0.84	4.36	2.96	6.05	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	81.08	16.61	0.79	1.19	6.72	1.19	1.58	1.19	2.77	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	65.73	14.93	0.97	0.58	5.23	0.19	1.74	2.52	2.91	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	73.87	19.63	2.96	0.74	6.48	0.74	3.15	2.59	2.96	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	82.23	20.56	2.09	0.70	5.57	1.05	1.05	2.79	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	61.06	20.04	1.67	1.43	5.96	0.48	2.86	2.15	2.39	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	75.54	20.88	2.61	2.06	5.49	0.69	3.57	4.81	3.71	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	91.16	17.86	1.54	0.92	5.24	0.00	3.39	1.23	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	56.11	21.82	2.18	1.87	5.30	0.31	2.18	2.49	1.87	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	90.76	25.62	3.48	0.91	7.14	1.10	3.66	3.48	5.12	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	82.61	18.10	1.65	0.33	5.27	1.32	1.97	1.97	4.61	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	72.05	22.26	1.46	1.46	4.39	0.88	2.34	2.64	5.27	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	90.11	20.66	2.99	1.49	6.97	1.74	3.24	2.49	7.47	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	71.77	17.46	0.97	1.45	5.33	0.00	4.36	0.97	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	66.79	17.77	2.96	1.35	5.12	0.54	0.81	1.35	3.77	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	80.23	24.52	3.18	2.88	6.06	1.06	5.60	3.78	6.96	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	73.61	8.81	0.52	0.52	5.18	0.00	4.15	2.59	3.11	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	69.31	16.75	2.93	1.47	5.65	0.84	2.72	1.47	3.14	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	90.98	25.56	2.26	1.80	6.32	1.35	4.36	4.81	4.66	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	74.98	21.32	0.69	2.75	7.57	0.00	4.13	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	74.13	16.56	1.32	1.69	6.59	1.51	1.51	1.51	2.63	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	79.73	23.75	2.97	1.48	8.27	2.33	4.77	4.03	5.51	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	78.50	15.02	0.97	0.97	7.27	0.97	3.88	0.97	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	81.70	14.22	1.65	1.65	8.27	1.65	0.99	2.98	3.64	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	84.99	26.39	5.58	1.49	8.42	1.36	4.83	3.22	6.81	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	86.26	24.06	3.33	1.85	6.29	1.11	4.07	1.48	4.07	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	64.24	13.59	1.73	0.99	4.94	0.25	1.48	1.48	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	80.85	26.95	3.30	2.06	7.01	1.24	3.85	2.89	6.60	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	85.88	23.48	2.89	0.64	7.40	0.96	1.93	2.57	1.61	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	86.13	14.91	2.74	1.83	7.00	0.00	2.13	2.43	3.35	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	75.86	22.25	4.06	0.98	8.54	1.54	3.50	3.92	4.76	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	66.85	16.36	2.13	0.36	7.82	0.71	3.20	1.78	3.56	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	81.93	15.03	1.94	1.45	7.27	0.48	1.45	1.45	3.39	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	77.18	22.10	4.98	1.56	6.38	1.87	4.20	4.51	6.22	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	80.93	17.19	0.72	1.07	6.09	2.15	1.79	1.07	1.43	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	91.47	19.60	2.61	0.33	9.47	0.00	1.31	2.61	1.63	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	64.74	19.78	3.53	0.94	6.36	0.47	3.30	3.06	3.06	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	107.29	30.20	2.48	2.23	9.65	1.36	3.59	3.96	7.05	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	93.49	19.47	1.28	0.77	7.17	0.77	1.54	1.79	4.35	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	84.43	25.36	3.28	1.49	7.16	1.19	4.18	3.58	4.18	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.00	0.00	0.74	0.00	1.48	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.42	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.70	0.00	0.00	0.00	0.00	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	1.19	0.00	0.00	0.00	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	0.00	0.00	0.00	0.00	0.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	0.45	0.00	0.00	0.00	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	0.41	0.00	0.00	0.27	0.41	0.27	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.35	0.00	0.00	0.00	0.00	0.35	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	0.00	0.00	0.00	0.00	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	0.00	0.00	0.27	0.00	0.27	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	0.00	0.00	0.00	0.61	0.00	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	0.21	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	0.00	0.00	0.00	0.00	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.58	0.87	0.00	0.00	0.00	0.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	0.00	0.00	0.00	0.30	0.00	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	0.00	0.00	0.00	0.00	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.35	0.35	0.00	0.00	0.00	0.35	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.00	0.00	0.00	0.37	0.00	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.38	0.77	0.00	0.38	0.00	0.38	0.00	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.57	0.00	0.00	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.90	0.00	0.00	0.00	0.45	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.37	0.00	0.37	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	0.00	0.00	0.43	0.00	0.00	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.86	0.00	0.00	0.00	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.67	0.00	0.00	0.33	0.00	0.33	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	0.00	0.00	0.00	0.00	0.00	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	0.00	0.00	0.00	0.00	0.00	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	0.00	0.00	0.00	0.34	0.00	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.74	0.00	0.00	0.00	0.00	1.48	1.11	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	0.00	0.00	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	0.00	0.00	0.00	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.49	0.99	0.00	0.00	0.00	0.99	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	0.50	0.00	1.01	0.00	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	0.45	0.00	0.00	0.45	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.89	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	0.00	0.00	0.00	0.00	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	0.52	0.00	0.00	0.00	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	0.00	0.00	0.00	0.00	0.88	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	0.00	0.00	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.48	0.48	0.00	0.00	0.96	0.00	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	1.19	0.00	0.40	0.00	0.80	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.69	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	0.00	0.00	0.00	0.00	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.00	0.00	0.60	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.95	0.63	0.00	0.00	0.00	0.00	0.95	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	0.00	0.00	0.00	1.07	1.60	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	0.00	0.00	0.00	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.57	0.00	0.00	0.57	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1.25	0.00	0.00	0.00	0.42	0.42	0.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	0.00	0.00	0.00	0.00	0.78	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.42	0.00	0.00	0.00	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	0.46	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	0.00	0.00	0.00	0.00	0.00	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	1.60	0.00	0.00	1.07	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.81	0.00	0.00	0.00	0.40	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	0.57	0.00	0.00	0.00	0.00	0.00	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	0.00	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.55	0.00	0.00	0.00	0.00	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	0.45	0.00	0.00	0.45	0.89	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	0.26	0.00	0.00	0.26	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	1.33	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	63.13	34.42	7.75	0.68	4.33	4.79	4.79	8.20	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	24.59	19.64	27.53	0.18	21.29	4.22	3.67	6.79	2.20	0.92
Macrophage - monocyte derived, donor3	11389-118C3	49.94	34.61	29.76	1.18	14.68	4.98	3.41	5.77	2.23	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	4.78	2.66	0.53	0.00	0.00	1.59	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	78.12	12.83	1.11	1.11	4.91	1.43	1.90	0.95	1.90	0.48
Mallassez-derived cells, donor3	11930-125I4	31.13	6.12	1.53	0.56	2.36	1.11	2.22	0.83	1.11	0.42
Mammary Epithelial Cell, donor1	11273-116H4	13.15	4.88	0.90	1.00	3.49	0.70	2.19	0.40	1.00	0.80
Mammary Epithelial Cell, donor2	11350-117G9	9.27	3.19	0.00	0.87	2.90	0.87	2.03	0.87	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	13.47	10.23	0.25	0.50	3.24	0.50	1.75	0.25	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	16.27	0.00	0.00	1.36	2.71	0.00	0.00	0.00	2.03	0.68
Mast cell, donor1	11563-120D6	30.06	4.22	0.97	1.19	8.22	3.46	0.87	0.65	1.08	0.97
Mast cell, donor2	11565-120D8	43.98	8.02	2.67	1.19	4.75	5.05	5.65	3.27	0.30	1.49
Mast cell, donor3	11566-120D9	40.97	10.13	2.93	1.80	3.15	7.20	3.60	1.58	0.45	1.35
Mast cell, donor4	11567-120E1	26.24	9.04	2.30	0.71	4.43	5.50	2.30	3.90	0.35	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	17.96	1.44	1.66	0.22	2.22	2.11	0.11	0.55	1.55	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	8.76	0.58	0.58	0.58	5.25	1.75	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	29.60	4.82	1.61	0.69	1.03	3.90	0.46	0.34	0.80	0.69
Mast cell, expanded, donor8	11941-126A6	22.09	5.36	1.00	0.33	1.51	2.18	0.67	0.00	0.67	0.67
Melanocyte - dark, donor1	11502-119F8	26.96	21.09	1.89	1.09	3.58	2.49	2.89	2.98	2.49	0.40
Melanocyte - dark, donor2	11582-120F7	8.65	3.46	0.35	2.08	0.69	1.38	0.69	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	18.40	17.68	2.25	2.25	5.58	1.67	3.26	0.72	2.03	0.72
Melanocyte - light, donor1	11274-116H5	33.62	11.52	4.00	3.06	7.05	1.88	1.88	1.41	1.18	0.94
Melanocyte - light, donor2	11351-117H1	33.44	29.35	4.09	11.60	8.87	1.36	0.68	0.68	2.05	2.05
Melanocyte - light, donor3	11423-118G1	22.55	13.88	6.07	3.47	6.94	0.87	1.73	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	24.99	16.35	1.46	1.35	3.64	1.56	1.46	0.83	2.19	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	15.33	19.90	3.50	1.34	6.99	0.81	2.15	1.61	0.81	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	33.75	32.14	2.95	5.09	9.37	0.54	4.29	1.87	7.50	1.61
Meningeal Cells, donor1	11493-119E8	4.96	3.85	0.00	0.50	1.86	1.24	0.87	0.37	0.74	0.12
Meningeal Cells, donor2	11573-120E7	0.88	3.52	0.00	0.44	1.32	0.00	0.00	0.88	0.44	0.88
Meningeal Cells, donor3	11654-122E7	3.59	1.79	0.16	0.33	0.49	0.08	0.65	0.49	0.65	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	2.00	0.86	0.00	0.00	0.57	0.29	0.00	0.29	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.79	4.23	0.50	1.21	2.92	3.12	2.21	0.70	0.50	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	2.63	0.00	1.31	0.00	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	5.23	0.00	0.00	0.00	2.62	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2.87	2.15	1.44	0.72	0.00	0.00	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	2.75	1.27	0.42	0.64	1.91	0.85	0.64	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1.51	2.01	0.50	0.50	0.50	0.00	0.50	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.96	2.64	0.66	0.44	0.88	1.54	1.32	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	2.92	0.00	1.46	2.19	2.19	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.16	3.68	0.00	0.82	0.41	1.23	0.20	1.23	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.35	1.11	0.00	0.14	0.42	1.11	0.14	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.01	10.04	0.74	4.83	5.20	0.00	1.12	0.74	0.37	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	12.50	7.24	0.66	4.08	3.16	1.58	0.66	0.13	1.97	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	2.08	0.30	0.89	0.59	0.59	1.19	0.00	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.04	7.68	0.64	1.92	0.64	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.13	1.42	0.35	0.00	0.35	0.35	0.00	0.35	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.19	4.69	0.63	1.88	3.13	0.94	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	4.35	4.35	0.73	0.00	2.90	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	71.33	17.50	3.45	1.86	9.28	5.57	2.65	1.86	2.39	0.27
Mesothelial Cells, donor2	12156-128G5	50.55	12.01	3.50	1.50	4.00	2.00	2.00	1.00	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	47.41	12.57	2.60	1.88	4.70	4.55	1.81	0.87	3.04	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	27.01	13.50	0.00	8.10	10.80	5.40	2.70	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.02	33.49	35.71	1.97	27.83	3.69	3.69	7.63	1.23	2.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	24.73	17.67	27.09	2.65	28.56	4.12	2.94	5.01	2.94	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	34.57	24.20	0.00	24.20	0.00	17.29	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.75	26.04	25.42	1.55	11.47	1.86	0.93	4.34	1.86	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.61	13.90	18.05	0.62	17.42	2.49	2.49	5.60	2.70	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	30.11	23.16	0.00	4.63	2.32	0.00	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.54	32.28	29.53	1.50	23.02	5.76	3.75	8.01	3.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	28.86	27.93	0.47	20.48	4.65	3.26	7.91	1.86	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	38.93	0.00	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	38.20	25.61	24.18	1.63	17.68	4.67	2.64	5.69	1.83	2.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.53	15.84	29.30	0.40	25.74	5.54	3.56	6.73	0.79	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	8.55	17.10	0.00	0.00	8.55	8.55	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	19.47	17.70	0.00	15.93	2.65	0.00	5.31	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	11.40	25.84	1.14	23.56	2.28	2.28	6.08	2.28	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	55.27	27.63	14.47	2.63	10.53	1.32	5.26	2.63	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	42.66	20.37	20.80	1.70	19.52	2.76	1.91	2.76	4.46	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	23.94	17.50	0.92	17.50	0.00	0.92	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	62.89	23.84	22.06	2.38	29.51	2.68	4.17	5.07	1.79	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	26.83	3.35	0.00	13.41	5.03	1.68	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	49.93	24.09	16.31	3.01	27.60	2.76	4.27	5.52	3.26	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.23	14.50	21.63	0.95	19.25	1.90	1.90	4.99	1.43	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	76.85	13.27	13.27	0.00	9.95	1.11	4.42	2.21	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	61.94	20.26	15.89	1.84	31.77	1.61	3.91	3.45	1.38	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	36.39	16.41	22.51	0.42	26.71	2.10	4.21	5.05	2.73	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	76.84	22.83	13.66	2.04	35.47	3.26	4.08	3.06	3.47	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	58.78	17.59	19.52	1.29	23.17	3.65	3.65	4.08	2.15	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.68	20.01	18.45	0.89	20.01	4.45	2.67	6.67	1.78	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	30.96	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	79.72	18.18	13.36	1.75	33.07	1.75	2.85	2.19	2.41	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	46.13	17.74	13.69	1.01	20.79	3.04	1.01	2.53	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	94.45	26.51	4.97	0.00	14.91	0.00	1.66	4.97	1.66	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	103.82	22.56	16.04	1.63	28.81	2.45	4.35	5.71	1.09	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	42.05	16.76	16.76	1.47	27.06	2.65	2.65	4.12	1.18	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	70.87	22.90	10.90	2.18	18.54	3.27	1.09	3.27	4.36	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	76.41	12.01	7.69	1.44	23.55	1.44	3.36	3.36	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	48.03	10.01	20.81	0.80	28.42	2.00	4.00	5.20	3.60	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	74.05	31.54	4.11	0.00	15.08	2.74	2.74	2.74	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	88.60	19.52	11.01	1.00	28.53	2.00	4.51	4.51	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	0.00	26.95	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	67.27	22.42	4.08	2.04	10.19	4.08	6.12	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	97.22	17.52	11.39	0.44	21.90	0.88	2.63	3.94	1.31	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	48.56	36.42	13.24	0.00	18.76	3.31	2.21	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	83.25	31.38	8.33	0.00	16.01	2.56	1.92	3.84	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	121.98	23.80	12.15	1.24	25.54	1.49	4.46	3.72	3.97	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	70.29	28.53	6.96	0.00	22.27	3.48	3.48	4.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	134.80	39.78	13.26	0.00	15.47	2.21	4.42	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	156.24	21.88	14.70	1.37	14.02	2.05	3.76	4.44	4.79	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	69.14	28.44	14.44	0.88	16.63	4.38	2.63	4.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	115.05	42.26	10.30	1.07	7.46	2.84	3.20	6.75	0.71	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	153.74	23.01	10.10	2.52	15.71	2.24	5.33	4.49	3.37	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	86.87	23.69	17.04	1.25	17.46	4.57	3.74	6.23	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	108.97	33.22	6.41	0.00	8.16	1.17	2.91	6.41	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	184.32	29.56	12.07	2.11	17.19	2.71	8.75	6.03	3.62	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	79.30	21.70	20.03	1.25	17.95	5.01	2.92	6.26	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	144.38	72.19	21.66	0.00	21.66	14.44	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	196.72	34.17	10.16	0.00	12.01	2.77	6.46	5.54	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	101.30	33.01	11.38	2.28	25.04	4.55	2.85	5.12	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	118.97	31.78	17.96	0.69	8.15	3.45	3.87	7.32	0.97	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	148.23	21.25	14.51	1.04	12.96	2.85	5.70	8.81	3.89	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	95.66	33.03	21.88	0.00	15.44	5.15	2.14	4.72	2.14	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	109.89	31.76	6.99	0.00	10.80	0.64	3.18	11.43	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	184.69	29.62	15.48	1.07	12.01	4.27	7.47	9.07	1.33	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	98.18	43.70	34.12	1.80	23.35	5.09	7.78	8.08	3.89	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	110.04	36.44	14.13	0.85	10.45	1.84	1.98	7.06	0.85	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	142.69	21.34	16.24	2.23	12.74	2.55	7.96	6.69	3.19	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	82.48	31.18	24.10	0.88	17.47	4.64	4.42	6.63	1.77	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	125.14	34.51	14.41	0.00	9.86	3.03	3.79	10.24	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	158.53	28.69	18.18	1.70	15.34	1.42	5.97	7.67	1.99	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	113.07	32.20	28.51	0.74	23.11	5.90	5.65	8.11	4.92	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	127.08	46.92	15.64	2.61	11.73	1.30	7.17	9.12	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	177.00	44.69	34.40	1.76	16.17	2.65	5.88	9.41	1.76	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	83.04	42.38	42.38	1.73	16.72	6.05	6.34	9.51	5.19	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	133.95	34.21	37.09	3.71	17.31	3.71	6.59	14.01	3.71	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	178.67	53.30	47.94	2.08	13.40	2.68	5.06	8.64	2.08	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	11.30	0.00	0.00	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	14.26	10.69	5.35	5.35	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	44.36	33.51	17.41	0.99	4.60	1.97	3.29	6.24	5.59	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	41.03	23.14	14.73	1.05	11.57	3.16	1.05	5.26	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	43.49	43.10	26.69	1.78	12.65	2.17	2.97	7.51	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	53.09	63.33	36.32	3.73	29.80	1.86	0.93	2.79	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	48.07	48.44	18.78	4.51	13.14	3.00	5.26	7.51	2.25	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	31.16	31.96	21.84	1.60	17.58	3.73	2.66	4.26	4.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.44	19.79	15.04	0.57	3.62	1.13	1.24	3.85	0.57	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.21	38.31	16.94	2.21	6.63	2.21	2.21	5.16	2.95	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	44.70	31.15	10.99	2.20	4.76	2.20	3.66	4.76	3.30	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	29.56	24.89	0.00	15.56	3.11	4.67	6.22	6.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	36.34	20.84	20.84	1.07	12.29	1.60	2.67	2.67	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	7.73	3.86	0.00	3.86	0.00	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	40.40	38.38	19.19	4.04	4.04	2.02	6.06	3.03	2.02	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	32.04	29.51	18.97	0.42	16.02	5.48	0.84	4.64	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	23.15	6.81	0.00	4.09	9.53	5.45	2.72	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	3.18	2.54	0.64	3.81	1.27	1.27	1.91	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	3.24	2.43	0.00	0.81	1.62	8.10	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	36.25	12.08	1.51	15.10	1.51	6.04	1.51	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	148.46	45.68	28.55	0.00	0.00	34.26	39.97	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	3.26	3.26	3.26	19.57	9.79	19.57	6.52	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	128.32	14.26	28.51	0.00	19.01	0.00	0.00	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	50.20	0.00	0.00	0.00	25.10	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.00	4.74	2.15	1.08	1.72	1.08	1.29	0.86	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	13.07	1.05	2.61	4.18	0.52	1.05	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	12.68	0.00	1.33	1.33	0.00	2.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	15.86	0.00	0.42	0.83	2.50	0.42	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.65	4.56	0.38	0.19	0.95	1.71	1.14	0.57	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	14.36	0.00	0.00	1.60	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.04	14.96	0.00	0.68	4.76	0.68	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	0.00	0.00	0.00	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	5.86	0.84	0.84	1.26	0.42	0.42	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.44	8.37	0.46	1.16	0.46	0.23	0.93	0.46	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.03	12.16	1.89	2.16	1.62	0.81	1.08	0.54	0.00	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.35	8.62	0.21	2.73	2.94	0.42	1.05	0.63	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	4.96	0.00	1.99	0.99	0.99	1.49	2.98	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	4.06	0.27	1.89	0.27	0.81	0.81	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	7.25	0.45	1.81	1.81	0.68	0.68	0.91	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.17	11.59	0.65	1.47	2.94	0.49	0.65	0.65	0.16	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	23.69	12.39	1.64	3.65	4.37	1.64	1.82	0.55	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	12.73	0.00	1.59	2.12	1.06	1.06	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.81	17.41	1.20	0.00	9.00	1.20	2.40	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.91	1.31	1.31	0.98	1.31	0.00	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.71	15.61	0.98	2.60	2.44	0.33	2.44	1.46	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.75	14.64	1.76	2.29	4.76	2.65	1.41	1.76	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	16.17	0.70	1.41	7.03	2.81	2.11	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.95	12.87	1.38	2.76	1.38	1.38	2.76	1.38	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.96	9.64	0.64	0.64	2.57	1.29	1.61	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.97	3.10	1.38	2.41	2.76	0.69	0.69	0.69	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	2.53	2.53	2.53	0.00	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.26	14.93	1.34	3.79	4.23	0.45	0.67	0.67	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	12.70	0.42	5.93	5.93	0.42	2.96	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	6.88	0.47	2.85	2.14	2.37	0.71	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	13.74	0.86	1.29	3.86	0.86	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	14.33	1.33	2.33	2.00	0.67	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.84	14.88	0.45	2.25	0.90	0.90	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	5.56	1.59	1.59	3.97	0.40	1.19	0.40	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	16.72	1.86	2.79	7.43	2.79	6.50	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	7.19	0.38	0.38	3.03	2.65	1.14	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.43	16.29	0.65	2.93	4.24	0.65	3.58	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	17.43	0.87	4.36	3.92	1.31	0.87	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	8.14	0.90	4.07	1.81	0.90	1.81	1.81	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	14.99	1.76	0.00	6.17	0.00	0.88	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	14.63	0.66	1.33	4.65	0.66	1.99	3.32	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	14.88	0.50	0.99	7.44	1.98	1.49	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	16.08	0.00	2.30	6.13	1.15	1.53	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.28	5.75	0.60	3.02	5.14	3.02	0.91	0.60	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.02	9.28	2.21	1.33	3.98	1.99	1.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	9.49	1.36	3.39	6.78	0.68	1.36	2.03	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	5.11	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	10.97	1.22	4.27	1.83	2.44	3.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	16.05	0.63	1.26	7.24	2.20	1.57	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	13.32	0.91	1.82	3.93	1.21	2.12	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	10.28	0.00	5.54	3.96	1.58	3.16	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	0.00	1.13	2.27	2.27	0.00	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	19.13	5.47	1.99	1.86	2.36	0.87	1.49	0.75	0.12	0.37
Myoblast, donor2	11322-117D8	14.58	5.75	1.15	0.96	1.73	2.11	0.77	1.73	1.15	0.19
Myoblast, donor3	11398-118D3	52.47	15.64	1.35	2.52	6.39	2.69	3.36	1.51	1.68	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	3.38	1.85	1.85	0.31	0.62	0.00	0.62	1.23	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	4.79	0.18	0.92	0.18	0.55	0.18	0.74	0.55	0.18	0.00
Neural stem cells, donor1	11275-116H6	15.97	5.44	0.36	6.90	7.62	0.36	1.45	0.73	3.99	1.09
Neural stem cells, donor2	11352-117H2	17.33	3.85	0.00	7.70	1.93	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	10.24	3.41	0.00	2.28	5.69	1.14	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	5.50	2.42	1.10	1.10	0.66	0.22	0.44	0.22	0.22	0.22
Neurons, donor3	11655-122E8	8.22	4.11	0.00	0.82	2.47	0.00	1.64	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	103.01	25.06	33.41	4.64	8.35	5.57	21.34	37.12	10.21	3.71
Neutrophils, donor2	11314-117C9	113.06	28.99	34.79	0.00	2.90	8.70	23.19	49.28	55.08	14.49
Neutrophils, donor3	11390-118C4	136.22	50.09	47.03	3.05	11.00	25.04	23.21	56.81	14.05	9.16
Nucleus Pulposus Cell, donor1	11252-116F1	2.97	2.37	0.36	2.97	1.66	0.12	0.71	0.12	0.83	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	3.26	1.30	0.65	3.58	0.65	0.33	0.00	0.00	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	1.40	4.21	0.20	0.60	0.80	0.20	0.00	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	4.54	9.36	0.55	0.69	2.34	1.24	1.24	0.83	0.83	0.69
Olfactory epithelial cells, donor2	11934-125I8	3.76	4.78	0.43	0.87	1.59	0.29	0.29	0.72	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	2.38	3.52	0.23	0.68	1.14	0.45	0.68	0.45	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	10.42	7.30	0.78	0.49	3.12	1.27	1.36	0.97	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	3.01	1.81	0.00	0.00	1.81	1.20	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.38	2.98	0.85	1.91	1.91	1.49	0.85	0.43	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	4.57	1.14	0.00	1.14	4.57	3.43	2.29	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.07	5.59	0.00	1.86	0.62	0.62	0.62	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	13.68	8.99	1.17	5.28	5.28	0.98	0.78	0.78	0.20	1.17
Osteoblast, donor2	11354-117H4	16.15	3.51	0.70	0.00	0.70	0.00	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	12.97	7.82	1.42	1.42	3.73	1.07	0.53	0.53	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	12.05	5.39	0.93	1.10	1.60	1.26	0.93	0.34	0.93	0.67
Pericytes, donor1	11491-119E6	1.45	3.23	0.11	1.22	2.00	0.56	0.56	0.22	0.00	0.11
Pericytes, donor2	11571-120E5	1.36	2.49	0.23	1.58	0.91	0.91	0.91	0.00	0.68	0.00
Pericytes, donor3	11652-122E5	6.51	2.24	1.02	0.20	0.20	0.41	0.20	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	2.49	0.79	0.11	0.23	0.23	0.11	0.23	0.11	0.11	0.11
Perineurial Cells, donor2	11579-120F4	7.45	3.50	0.18	0.74	1.10	0.92	0.92	1.01	0.92	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	19.76	6.06	4.46	0.96	3.19	1.91	1.27	6.69	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.45	6.86	3.43	0.24	1.96	2.45	4.90	7.59	1.22	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.61	7.76	6.47	0.52	1.04	1.16	1.94	5.44	1.55	0.00
Placental Epithelial Cells, donor1	11278-116H9	0.48	1.43	0.00	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	2.22	0.00	0.00	1.11	0.00	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.14	2.16	0.79	0.98	0.59	0.79	0.79	0.00	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	34.18	10.76	2.85	2.85	3.48	3.48	1.27	1.58	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	43.71	9.94	3.19	5.63	6.75	2.25	4.31	1.88	1.31	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	28.19	3.65	2.61	3.39	5.74	0.91	0.52	1.57	0.52	0.39
Preadipocyte - breast, donor2	11328-117E5	36.25	10.36	5.40	4.28	4.50	1.35	2.03	2.70	3.15	0.23
Preadipocyte - omental, donor1	11468-119C1	63.51	13.64	3.30	8.84	9.91	3.94	4.37	3.94	1.81	1.07
Preadipocyte - omental, donor2	11329-117E6	40.16	10.48	2.18	5.67	8.29	4.36	4.80	3.06	2.62	1.31
Preadipocyte - omental, donor3	11403-118D8	82.80	16.47	5.16	5.73	10.31	5.44	3.87	3.72	2.58	0.72
Preadipocyte - perirenal, donor1	11469-119C2	22.64	11.81	0.98	0.98	2.95	0.98	1.97	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	6.76	0.92	1.23	3.69	0.92	0.92	0.31	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	14.34	5.14	1.24	0.89	3.90	0.89	0.35	0.35	1.95	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	10.73	4.60	0.85	1.36	2.04	1.70	0.85	0.51	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	15.46	5.40	0.75	1.30	1.21	1.30	0.47	0.56	1.40	0.37
Preadipocyte - visceral, donor2	11357-117H7	12.89	5.06	1.38	1.38	0.92	0.46	0.00	0.00	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.05	5.54	0.94	0.84	1.46	1.36	1.04	0.63	0.42	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2.11	3.32	0.15	0.00	3.47	0.60	1.96	0.91	0.60	0.75
Prostate Epithelial Cells, donor2	11331-117E8	44.96	13.81	4.20	1.49	5.96	2.44	5.28	1.08	3.25	1.22
Prostate Epithelial Cells, donor3	11404-118D9	5.70	2.76	0.55	0.06	1.22	0.73	1.10	0.43	0.73	0.24
Prostate Stromal Cells, donor1	11254-116F3	9.57	3.19	0.34	1.25	1.94	0.34	0.57	0.34	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	2.33	2.51	0.36	0.18	0.90	0.18	0.54	0.54	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	4.17	4.17	0.42	0.83	1.15	1.15	0.63	0.52	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.58	16.06	0.73	0.00	5.11	1.82	1.46	1.09	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.05	5.96	0.83	0.35	2.43	0.97	0.55	0.49	1.32	0.42
Renal Epithelial Cells, donor1	11517-119H5	45.65	18.77	1.52	2.03	6.59	4.06	2.03	2.03	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	36.28	24.18	4.27	4.27	7.11	2.13	4.98	1.42	0.71	2.85
Renal Epithelial Cells, donor3	11678-122H4	29.32	9.42	1.80	0.95	3.39	1.69	0.95	0.74	2.01	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	8.17	0.00	0.68	0.00	0.68	0.68	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.58	7.28	0.54	0.00	0.27	0.81	0.54	0.54	0.40	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.98	10.66	1.11	0.67	2.66	0.22	0.89	0.67	0.22	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	5.99	1.33	0.00	0.00	2.00	0.67	1.33	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	15.85	9.02	1.10	0.88	7.26	3.52	1.10	0.88	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	18.81	8.15	1.88	2.51	5.02	3.13	1.25	2.51	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	15.54	9.43	1.66	2.50	8.04	2.22	1.94	0.55	0.83	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	58.78	20.67	2.42	0.54	5.64	2.42	3.22	2.15	0.54	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	26.14	11.81	2.53	0.42	3.37	1.27	1.27	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.61	21.98	1.54	2.12	10.61	0.96	2.31	1.35	1.54	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.44	2.59	0.26	0.26	1.04	0.00	1.04	0.26	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.25	2.84	0.57	1.14	2.27	1.42	0.57	0.00	0.28	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	3.09	0.00	1.03	0.00	1.03	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.27	2.26	0.00	1.51	3.76	0.25	1.25	0.75	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	8.82	8.69	5.35	0.94	1.07	2.14	4.81	5.35	1.87	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2.68	1.79	0.89	0.00	0.00	1.79	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.10	0.55	0.00	2.20	2.20	0.55	0.55	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.00	0.00	1.16	0.00	0.58	1.74	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	1.17	1.43	0.13	0.26	1.04	0.52	0.13	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1.39	1.49	0.79	0.20	0.70	0.40	0.60	0.30	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1.34	1.00	0.33	0.56	1.23	0.56	0.33	0.11	0.11	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1.74	1.24	0.12	0.62	0.87	0.50	0.12	0.00	0.25	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	2.68	1.86	0.47	0.00	0.70	0.58	0.00	0.12	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1.85	1.39	0.46	0.46	0.69	0.23	0.23	0.69	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1.64	2.46	0.27	0.27	1.10	0.14	0.14	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1.36	1.82	0.15	0.30	0.76	0.61	0.15	0.00	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2.33	0.90	0.18	0.18	0.72	0.00	0.00	0.00	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1.72	1.43	0.72	0.29	1.15	0.57	0.43	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	1.07	1.40	0.54	0.11	0.64	0.11	0.11	0.00	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	2.88	2.43	0.00	0.00	1.11	0.44	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1.34	1.91	0.19	0.19	0.38	0.96	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1.77	1.68	0.47	0.19	0.56	0.19	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1.69	1.13	0.38	0.19	0.94	0.56	0.38	0.19	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1.59	2.52	0.27	0.13	0.53	0.40	0.00	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1.75	1.75	0.29	0.10	0.49	0.68	0.10	0.39	0.29	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	0.57	0.95	0.95	0.19	0.38	0.95	0.38	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1.39	1.82	0.11	0.21	0.21	0.21	0.53	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	2.80	1.40	0.28	0.56	0.56	0.00	0.56	0.28	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1.03	1.20	0.00	0.34	0.68	0.00	0.34	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	0.73	1.82	0.73	0.55	0.73	0.00	0.73	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1.59	2.45	0.25	0.12	0.25	0.12	0.00	0.12	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2.15	1.61	0.13	0.27	0.54	0.13	0.40	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1.65	1.18	0.47	0.00	0.94	0.71	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1.59	1.39	0.20	0.60	1.39	0.40	0.40	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1.17	2.34	0.00	0.70	0.00	0.70	0.47	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1.66	1.87	0.21	0.21	1.04	0.00	0.21	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1.77	1.77	0.44	0.66	1.55	0.88	0.66	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	0.42	1.88	0.00	0.84	0.63	0.21	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	2.15	1.75	0.27	0.27	1.08	1.08	0.27	0.00	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1.02	1.87	0.17	0.51	0.68	0.17	0.00	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1.35	2.31	0.19	0.00	0.39	0.19	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2.24	2.41	0.34	0.17	0.52	0.00	0.69	0.00	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1.23	2.47	0.27	0.41	0.55	0.55	0.27	0.00	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	0.99	1.31	0.33	0.16	0.00	0.33	0.00	0.16	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1.36	1.70	0.34	0.34	0.00	0.68	0.17	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1.92	0.89	0.30	0.30	1.04	0.30	0.30	0.00	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1.33	2.13	0.53	0.00	1.07	0.00	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1.94	2.35	0.97	0.41	1.11	0.14	0.55	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1.90	0.48	0.48	0.00	0.48	0.48	0.48	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1.41	2.62	0.81	1.21	0.40	0.00	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.28	1.13	0.47	0.38	1.04	0.09	0.09	0.09	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	1.75	2.10	1.05	0.35	1.75	0.70	1.40	0.00	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1.21	1.51	0.30	0.60	0.30	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	1.10	1.71	0.73	0.24	0.37	0.37	0.24	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1.75	2.91	0.58	0.58	2.18	1.02	0.87	0.44	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	0.61	1.22	0.61	0.00	0.00	1.22	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	0.90	1.81	0.60	0.00	1.81	0.00	0.00	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2.71	3.62	2.71	1.13	2.94	0.45	0.23	0.00	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	3.59	3.00	1.20	0.60	1.20	0.60	0.00	0.30	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3.66	1.89	1.30	1.18	1.65	0.47	1.53	0.47	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	2.99	3.42	2.77	0.64	1.92	0.85	0.85	0.43	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	2.40	1.20	0.60	1.80	0.60	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.77	4.51	0.00	0.56	0.38	0.94	0.75	0.38	0.19	0.56
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	3.29	1.97	0.00	0.22	1.75	0.00	0.44	0.00	0.44	0.66
Sebocyte, donor1	11220-116B5	96.96	23.55	4.38	2.74	4.93	5.48	10.41	3.83	8.76	1.64
Sebocyte, donor2	11301-117B5	30.33	9.19	0.46	0.46	0.92	3.22	4.14	1.38	2.30	0.92
Sebocyte, donor3	11378-118B1	11.13	6.80	1.24	1.03	1.24	0.41	2.06	1.03	1.86	0.00
Sertoli Cells, donor1	11255-116F4	13.25	3.31	0.00	0.00	1.66	1.66	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	14.12	11.30	0.00	5.65	2.82	2.82	0.00	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	4.75	2.99	0.35	0.88	1.85	0.79	0.26	0.18	0.35	0.62
Skeletal Muscle Cells, donor2	11358-117H8	5.06	4.34	0.00	2.17	3.61	0.72	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	19.23	6.69	0.84	0.84	2.51	1.67	0.00	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	3.77	2.98	0.00	1.10	0.79	0.47	0.79	0.79	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	2.97	2.97	0.00	1.04	1.19	0.45	0.15	0.30	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	7.08	4.77	0.15	0.46	2.00	0.77	0.00	0.46	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6.68	2.27	0.38	2.90	1.13	0.38	0.25	0.13	0.76	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	6.56	2.14	0.43	2.00	0.86	0.43	0.14	0.00	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	5.56	4.27	0.60	1.29	1.59	0.50	0.40	0.10	0.40	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.74	2.78	1.10	2.02	4.13	0.76	0.42	0.51	0.59	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	7.96	1.45	0.72	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.74	3.99	0.96	1.51	2.75	1.24	0.69	0.41	0.83	0.28
Skin - palm, donor1	10286-104F7	10.74	10.74	0.00	2.69	8.06	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.20	8.36	1.87	0.43	3.17	1.15	1.44	1.01	0.43	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	40.08	7.36	3.27	0.00	7.36	3.27	3.27	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.08	8.44	1.43	0.52	2.86	1.30	2.47	0.52	0.39	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	2.36	1.53	0.14	1.67	0.97	1.11	0.42	0.70	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	22.93	10.27	0.84	0.56	3.52	1.83	4.36	0.84	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	33.20	13.96	2.11	0.63	9.30	3.59	4.44	1.90	0.42	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	8.69	6.00	1.12	0.75	2.17	0.82	1.80	0.60	0.30	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	1.54	0.62	0.00	1.23	2.78	0.31	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.35	4.45	2.00	0.67	2.22	4.00	1.33	0.89	2.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	4.11	0.59	0.59	1.18	1.18	0.00	1.76	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	25.64	3.54	0.88	0.22	0.88	0.44	0.22	0.88	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.23	5.12	1.18	0.39	2.36	1.58	1.58	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	7.73	0.00	0.77	1.55	1.55	0.77	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	3.00	0.00	3.00	1.00	0.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	24.89	6.52	0.40	1.46	1.46	1.60	1.86	0.67	0.80	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.31	1.99	0.00	0.89	1.11	1.99	0.66	0.22	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.60	4.99	0.13	0.51	0.77	1.15	0.64	0.77	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	0.33	1.95	0.33	0.00	0.00	0.33	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	2.36	3.54	0.59	0.59	1.18	0.00	0.00	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.83	3.56	0.00	0.28	0.43	0.85	0.85	0.71	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.33	7.48	0.00	0.98	3.58	1.30	1.30	0.98	1.46	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.00	6.39	0.00	2.74	3.04	0.91	0.30	1.22	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.65	5.05	0.51	1.77	2.02	1.26	1.26	1.26	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	6.12	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	4.29	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.44	2.95	0.15	1.18	1.33	1.47	0.44	0.15	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.07	4.52	0.43	1.94	1.08	0.86	0.43	0.43	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.34	5.35	0.42	1.36	1.26	0.84	0.21	0.31	0.10	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.18	7.89	1.39	1.24	2.63	2.47	1.39	0.77	0.00	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	2.16	1.08	0.00	1.08	0.00	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.93	7.77	0.30	0.60	0.90	0.90	0.60	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.39	8.19	0.34	3.41	4.44	1.71	0.00	1.02	0.68	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.29	4.08	0.63	2.75	1.81	1.41	1.10	0.39	1.10	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.30	3.93	1.21	2.11	1.81	2.01	0.91	0.40	1.41	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.26	7.96	2.05	1.14	1.37	0.91	1.82	1.14	2.73	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	34.42	8.45	0.60	0.00	1.81	0.60	3.02	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.10	7.68	0.00	0.79	2.12	0.26	0.53	0.79	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	4.93	4.26	0.13	0.40	0.80	0.67	0.80	0.00	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.27	8.26	1.00	2.88	3.26	1.00	0.88	0.75	1.63	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	0.76	0.51	0.00	0.76	0.25	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.19	4.37	0.75	0.75	0.90	0.60	1.06	0.75	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	3.00	2.25	2.25	3.00	0.00	0.75	0.00	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	37.47	31.01	3.88	1.29	2.58	1.29	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.42	6.51	0.93	1.40	1.40	0.47	1.86	1.40	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	30.80	9.09	0.50	1.51	1.51	0.50	2.02	0.50	3.03	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.37	10.34	2.19	0.63	3.13	3.45	3.13	1.57	0.31	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.26	4.13	0.00	1.47	1.18	0.88	1.18	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.25	4.83	0.08	0.75	0.83	0.08	0.58	0.83	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.07	5.14	0.47	3.74	2.34	0.47	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.95	5.76	0.72	0.29	2.16	1.44	1.30	0.58	0.14	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.42	8.67	1.02	0.76	1.27	1.53	2.55	1.53	1.02	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	5.08	0.19	0.56	0.75	0.75	0.56	0.56	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.55	4.19	0.42	0.42	0.56	0.56	0.28	0.42	0.84	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.84	5.87	0.34	0.92	2.43	1.01	1.34	0.50	0.42	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	1.43	0.48	0.00	0.95	0.48	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.99	5.14	0.73	0.24	1.47	2.20	1.47	0.49	0.73	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.80	5.08	1.55	2.87	8.40	2.43	0.88	0.44	0.44	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.48	3.80	0.29	0.29	0.88	0.88	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.69	6.41	0.19	2.53	1.94	1.94	0.78	0.39	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.34	5.82	0.53	2.38	2.38	1.06	2.12	1.32	0.79	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.98	1.12	0.00	2.60	1.12	0.00	0.74	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.19	3.59	0.00	0.72	1.44	0.72	0.72	1.08	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	6.25	2.84	0.28	0.28	1.70	0.57	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.48	4.33	0.39	0.79	0.39	0.00	0.00	1.18	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.40	2.79	0.25	1.78	2.54	1.78	0.76	1.02	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	24.76	6.79	1.20	3.59	1.60	5.19	0.40	0.40	0.80	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	3.34	0.84	1.25	2.51	2.09	0.00	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	7.79	1.83	0.00	0.92	2.29	3.21	1.38	1.83	0.46	0.00
Synoviocyte, donor1	11291-117A4	12.96	2.52	1.01	1.18	5.05	1.51	1.68	1.51	1.01	0.17
Synoviocyte, donor2	11368-117I9	64.20	16.09	2.35	9.89	10.06	2.51	4.86	2.01	3.52	0.84
Synoviocyte, donor3	11440-118H9	38.20	17.65	1.79	5.59	5.36	2.23	2.68	2.46	2.01	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	10.36	6.79	0.36	1.43	2.86	0.36	1.07	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	5.95	1.98	0.00	1.98	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	13.20	7.18	0.46	1.39	1.39	0.93	0.46	1.16	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	14.12	3.73	1.00	0.57	1.00	0.57	1.94	0.65	0.22	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	3.87	1.55	0.77	2.32	1.16	0.77	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	5.15	0.00	1.15	1.72	1.15	2.86	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.46	7.38	4.31	0.86	1.85	1.23	3.69	3.32	0.37	0.62
Urethra, donor2	10319-105A4	8.99	7.19	0.00	0.00	0.00	5.40	1.80	0.00	0.00	3.60
Urothelial Cells, donor1	11520-119H8	71.46	15.41	3.72	1.59	6.91	4.52	4.25	1.06	2.39	0.27
Urothelial Cells, donor2	11600-120H7	48.47	10.82	2.00	0.80	3.61	1.20	2.40	0.40	0.80	0.40
Urothelial Cells, donor3	11681-122H7	64.41	19.71	2.75	0.46	6.88	2.75	3.44	0.46	1.60	1.15
Urothelial cells, donor0	11216-116B1	102.31	20.95	6.46	0.89	9.81	4.46	3.12	0.67	6.02	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.91	20.47	17.80	0.89	4.45	4.45	6.23	8.90	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	27.16	21.44	0.00	0.00	10.01	4.29	10.01	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.07	17.80	17.11	0.00	1.37	4.79	3.42	10.95	9.58	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.69	11.36	7.58	0.34	0.00	3.10	5.51	7.58	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.08	6.39	8.72	0.58	1.74	2.91	3.49	11.04	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	16.66	17.70	1.04	4.16	10.41	5.21	13.54	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.94	13.77	10.10	0.92	3.67	6.42	4.59	8.26	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	10.04	17.35	0.00	0.00	3.65	2.74	11.87	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	1.48	6.17	0.37	0.49	2.47	0.00	0.49	0.25	0.25	0.49
Wilms' tumor cell line:HFWT	10597-108E3	0.88	6.16	0.00	0.88	1.76	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1.40	3.07	0.28	0.28	2.23	0.56	1.68	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	18.60	2.07	0.00	2.07	2.07	0.00	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1.53	4.33	2.55	0.51	2.04	1.27	1.53	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	2.18	0.00	0.00	0.27	0.00	0.54	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.69	1.12	2.81	0.00	0.00	0.28	0.84	0.00	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	10.57	6.34	5.71	0.21	1.48	0.85	1.27	0.21	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.35	4.90	9.53	1.36	0.82	0.82	0.82	0.00	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.08	4.85	3.53	0.44	0.00	1.76	0.44	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	12.25	10.62	7.76	0.00	1.23	0.41	0.41	0.00	2.04	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	5.05	6.60	9.71	0.00	0.78	0.78	0.78	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.30	12.88	18.58	0.18	1.66	2.21	0.92	0.18	3.13	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	7.80	3.90	3.90	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.30	9.99	9.76	0.23	2.32	0.46	0.23	0.23	0.70	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.94	11.13	23.30	0.52	0.52	2.33	0.26	0.00	2.07	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	6.14	7.01	9.64	1.46	0.88	0.58	0.58	0.58	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.31	20.91	18.59	1.39	2.32	1.86	3.72	1.39	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	22.62	12.75	24.68	0.00	2.06	2.06	0.41	0.00	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.53	7.98	38.68	0.31	0.92	1.53	0.31	0.31	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2.13	3.41	22.62	0.43	0.00	0.00	0.43	0.00	2.13	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.03	1.52	27.60	0.00	0.30	0.00	0.30	0.30	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.09	4.33	21.66	0.00	0.96	1.20	0.48	0.00	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.49	11.81	21.38	0.45	1.11	0.45	2.00	1.11	2.23	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.39	4.90	1.88	0.00	3.01	0.75	0.38	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	5.89	14.13	1.18	1.65	1.18	4.24	1.88	0.94	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	25.28	10.70	6.67	3.10	3.10	2.48	2.33	4.96	3.10	0.78
adipose, donor1	10184-103D4	0.59	0.59	0.59	0.00	0.59	0.59	0.59	0.00	1.17	1.17
adipose, donor2	10185-103D5	2.43	1.62	0.00	0.41	1.62	0.41	0.41	0.00	0.00	1.62
adipose, donor3	10186-103D6	46.83	1.09	0.00	1.09	1.36	0.00	2.18	0.00	0.00	0.54
adipose, donor4	10187-103D7	111.81	1.73	0.00	0.00	0.00	0.00	0.87	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.95	7.58	0.16	0.47	0.95	1.42	0.95	0.00	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	58.20	10.91	3.64	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.22	22.87	0.36	0.00	3.57	1.43	0.36	0.00	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	1.35	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	73.52	15.42	113.84	29.64	17.79	9.49	3.56	0.00	4.74	1.19
amygdala, adult, donor10252	10151-102I7	61.84	21.29	103.21	50.29	18.45	4.87	2.64	2.03	7.71	1.62
amygdala, newborn, donor10223	10360-105E9	59.71	4.52	95.86	18.40	19.69	4.52	1.94	0.32	2.58	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	42.53	17.44	0.89	2.42	4.58	2.55	2.04	3.95	1.78	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.00	1.67	0.00	0.33	5.34	0.33	1.00	0.00	0.00	1.00
aorta, adult, pool1	10052-101G7	10.79	5.49	1.37	2.16	2.35	0.98	0.98	1.37	0.20	0.39
appendix, adult	10189-103D9	5.05	7.37	3.49	0.78	1.94	1.94	0.78	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	3.44	9.63	0.34	1.72	5.16	2.06	1.38	0.34	0.34	2.41
artery, adult	10190-103E1	9.51	2.72	0.00	1.36	1.36	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	3.62	3.77	0.14	0.43	1.59	0.87	1.45	0.29	0.72	0.87
b cell line:RPMI1788	10427-106D4	6.39	3.12	2.08	0.45	1.93	2.08	1.04	0.15	1.19	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	10.82	4.72	1.39	0.83	0.55	2.50	0.28	0.28	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	2.08	1.39	0.10	0.20	0.40	0.50	0.10	0.30	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	3.01	2.01	0.33	0.50	0.17	1.67	1.17	1.17	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.30	7.83	21.25	1.68	1.12	2.80	2.80	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	14.99	5.00	1.63	1.63	1.74	0.98	0.87	0.43	0.76	0.22
blood, adult, pool1	10053-101G8	8.86	4.43	4.43	0.00	0.00	0.00	4.43	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	26.55	8.56	0.86	0.86	0.00	0.86	2.57	0.86	0.00	0.00
bone marrow, adult	10192-103E3	20.92	8.10	2.70	0.67	0.00	0.67	0.00	0.00	3.37	0.67
brain, adult, donor1	10084-102B3	107.63	19.48	35.88	52.28	27.68	8.20	7.18	3.08	5.13	1.03
brain, adult, pool1	10012-101C3	103.23	11.25	40.53	41.76	19.82	15.59	6.12	1.56	6.01	3.45
brain, fetal, pool1	10085-102B4	32.06	5.34	13.36	8.01	0.00	8.01	5.34	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	0.00	0.33	0.00	0.00	0.00	0.00	0.33	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	3.50	9.24	1.25	3.74	1.25	3.00	7.61	1.25	0.37	0.75
breast, adult, donor1	10080-102A8	22.10	21.47	1.89	1.26	3.79	3.16	3.16	1.89	2.53	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2.79	6.48	0.38	0.51	1.27	1.27	4.57	0.38	0.76	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.47	0.94	0.00	0.00	0.00	0.00	0.47	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	0.98	1.97	0.00	0.44	0.22	0.88	0.88	0.22	0.00	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	10.46	17.75	1.58	6.02	0.95	1.27	1.90	0.00	1.27	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	2.93	3.99	0.00	0.53	5.59	0.53	0.80	0.27	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	73.68	6.91	31.09	24.18	9.21	5.76	3.45	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	64.92	13.22	45.35	35.81	13.55	8.87	2.01	2.51	4.85	1.00
caudate nucleus, adult, donor10258	10379-105H1	71.06	6.88	48.14	20.63	7.64	12.99	1.53	0.00	3.06	2.29
caudate nucleus, newborn, donor10223	10354-105E3	30.40	3.30	70.68	12.09	8.06	5.86	1.46	1.46	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	101.96	29.13	0.00	64.09	29.13	8.74	11.65	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	114.44	30.10	5.98	85.40	19.86	27.33	13.88	6.41	15.59	2.14
cerebellum, adult, pool1	10083-102B2	80.03	18.28	4.48	46.91	18.63	6.90	8.97	3.45	4.83	1.38
cerebellum, newborn, donor10223	10357-105E6	117.90	2.49	3.32	44.01	46.50	4.15	9.96	0.00	4.98	0.83
cerebral meninges, adult	10188-103D8	65.30	9.58	49.42	31.01	17.15	7.82	5.04	0.76	1.76	2.27
cerebrospinal fluid, donor2	10294-104G6	19.00	2.19	2.19	0.73	2.19	6.58	0.00	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	2.88	1.29	0.29	1.01	0.72	0.72	1.01	0.72	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	3.15	6.79	0.00	0.83	1.66	2.49	14.91	0.50	0.66	0.33
cervix, adult, pool1	10013-101C4	13.33	3.57	2.62	3.25	1.78	1.78	1.78	1.26	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	65.07	21.88	0.42	3.34	9.20	1.25	4.46	8.50	1.95	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	30.04	0.00	0.00	1.31	3.92	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.12	0.25	0.00	0.12	0.12	0.37	0.00	0.25	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.00	0.37	0.00	0.00	0.00	0.12	0.37	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.24	1.42	0.24	0.00	0.47	0.24	0.71	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	0.57	0.28	0.00	0.00	0.00	0.00	0.00	0.57	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	2.09	1.69	0.50	0.10	0.40	0.60	0.00	0.00	0.20	0.40
chorionic membrane cells, donor3	12240-129G8	2.75	2.20	0.55	0.00	0.00	1.10	0.00	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	2.31	2.31	1.54	0.19	0.38	0.38	0.00	0.00	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	69.95	16.23	1.14	1.37	1.60	1.60	0.69	0.46	2.97	1.14
clear cell carcinoma cell line:TEN	10636-108I6	4.86	6.25	0.00	0.00	1.39	1.91	1.39	0.17	1.04	0.17
colon carcinoma cell line:CACO-2	10513-107D9	2.01	6.77	0.18	0.18	2.20	0.18	2.01	0.37	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	3.57	3.57	1.19	1.19	0.00	2.38	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	8.70	5.41	1.53	1.88	2.70	1.65	1.76	1.06	0.12	0.12
colon, fetal, donor1	10070-101I7	3.71	6.18	1.24	1.24	1.85	0.62	0.00	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	9.17	0.00	0.00	4.58	0.00	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	0.00	0.00	0.00	0.00	2.12	0.85	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.00	0.60	0.00	0.15	1.96	0.60	0.60	0.15	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	0.42	0.99	0.00	0.00	0.99	0.85	0.56	0.28	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	92.10	12.38	8.18	32.39	14.70	6.08	5.86	4.98	4.09	1.11
cruciate ligament, donor2	10295-104G7	19.45	10.54	3.24	0.81	3.24	0.00	3.24	2.43	3.24	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	10.43	1.61	0.00	3.21	0.80	0.00	2.41	0.00	0.00
diencephalon, adult	10193-103E4	50.16	11.28	13.68	12.96	7.44	5.76	5.04	0.48	1.68	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.23	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	0.26	1.03	0.00	0.00	0.51	0.77	0.51	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.41	1.93	0.00	0.24	1.20	0.48	1.44	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	1.00	8.47	2.49	2.99	0.00	0.50	2.49	2.49	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	7.20	18.72	4.32	2.88	1.44	0.00	1.44	2.88	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.83	6.62	2.94	2.94	4.41	2.21	0.74	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	52.94	16.85	5.62	8.67	11.15	2.56	8.92	4.96	3.06	1.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	0.22	1.11	0.00	1.33	1.11	0.22	0.67	0.22	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	0.57	1.86	0.00	0.57	1.29	0.29	0.72	0.43	0.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	5.55	11.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	11.81	9.69	0.30	0.61	0.91	0.91	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.01	7.72	0.00	1.23	0.93	0.62	0.00	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	10.51	13.13	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.69	5.36	1.01	0.34	2.68	0.34	1.01	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	5.80	3.26	0.18	0.54	0.72	2.17	0.00	0.18	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	5.45	4.22	0.11	0.22	2.56	2.22	7.45	1.00	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	9.13	7.15	0.00	0.77	0.88	1.21	2.97	1.43	1.10	0.44
epididymis, adult	10197-103E8	11.72	7.12	1.67	2.51	3.98	2.30	1.88	1.47	1.47	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.03	6.03	0.00	0.35	0.35	0.53	0.35	0.00	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.79	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.00	0.00	0.00	0.00	0.11	0.00	0.00	0.11	0.00	0.00
esophagus, adult, pool1	10015-101C6	5.95	2.34	1.27	0.53	0.53	1.17	1.81	0.42	0.42	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.63	6.76	0.38	1.00	3.38	1.00	0.88	0.25	0.38	0.25
eye - muscle inferior rectus, donor1	10272-104E2	7.24	4.83	2.41	0.00	0.00	2.41	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	2.10	2.10	0.00	0.00	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	7.44	0.00	0.00	5.95	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	6.88	0.00	0.00	1.15	1.15	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	5.83	1.46	0.00	1.46	1.46	5.83	2.91	1.46	2.91
eye, fetal, donor1	10054-101G9	18.56	9.41	1.27	3.56	4.32	2.03	1.02	0.76	1.53	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	10.64	7.18	0.26	0.00	2.18	1.15	0.51	0.38	0.00	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1.90	5.46	0.00	0.24	0.24	0.00	0.24	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	104.90	16.04	85.85	56.58	29.93	16.51	6.38	2.25	7.60	4.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1.80	3.60	0.30	0.60	0.90	1.20	0.90	0.00	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.59	4.30	0.18	0.00	1.10	0.55	0.37	0.09	0.64	0.18
gall bladder, adult	10198-103E9	9.90	7.00	2.17	3.62	6.04	1.69	3.14	1.21	0.72	0.72
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.75	0.00	0.00	0.00	0.37	0.37	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	0.21	0.21	0.00	0.21	0.42	0.42	0.00	0.00	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.19	0.97	0.00	0.00	0.19	0.19	0.00	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	0.66	5.74	0.33	0.00	0.49	0.33	0.33	0.49	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	1.83	3.66	0.00	0.00	2.75	0.92	2.75	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	0.11	0.00	0.00	0.00	0.00	0.23	0.11	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	3.50	1.96	0.42	0.14	1.12	0.14	0.28	0.42	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.24	2.74	0.00	0.00	0.50	0.00	0.50	0.25	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	4.86	3.17	0.63	0.32	1.58	0.32	0.53	0.11	0.32	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	5.34	5.62	0.70	0.42	0.98	0.00	0.42	0.42	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	7.06	6.51	0.33	0.99	3.20	0.33	0.44	0.77	0.77	0.55
glioma cell line:GI-1	10413-106B8	10.25	3.22	0.88	2.34	2.05	0.88	0.29	0.29	0.88	0.59
globus pallidus - adult, donor10196	10175-103C4	64.14	10.93	13.12	13.85	8.75	3.64	0.73	0.00	2.19	2.92
globus pallidus, adult, donor10252	10161-103A8	62.00	14.89	12.20	31.98	7.08	4.64	3.42	5.13	5.37	0.49
globus pallidus, adult, donor10258	10367-105F7	41.08	4.11	15.06	19.17	4.11	4.11	1.37	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	38.37	4.26	19.19	11.19	2.66	4.26	4.26	2.13	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	31.81	12.24	2.45	0.00	4.89	4.89	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	0.00	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	8.32	0.00	0.64	0.96	1.60	0.00	1.28	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	4.13	0.00	0.92	1.38	2.75	0.92	0.46	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	4.57	1.37	2.74	1.37	0.91	0.00	0.46	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	1.29	1.29	0.00	0.64	0.64	0.00	1.29	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	4.31	0.00	0.00	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	1.37	2.74	0.00	0.00	0.69	0.00	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	78.35	8.83	7.72	27.59	12.14	14.35	4.41	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	5.17	3.74	1.15	0.29	5.46	2.01	0.86	0.00	0.00	0.57
heart - mitral valve, adult	10205-103F7	26.31	7.18	1.49	8.07	5.38	2.39	1.49	0.90	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	7.32	4.71	3.14	2.88	1.83	1.05	1.05	1.05	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	74.11	18.32	4.16	5.00	23.31	1.67	4.16	6.66	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	7.55	4.29	2.24	1.02	1.43	0.82	1.22	1.02	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	7.66	5.11	0.43	2.13	0.85	1.70	0.85	1.28	1.70	0.43
heart, adult, pool1	10016-101C7	12.42	4.83	3.68	3.45	0.92	0.92	0.46	2.30	0.00	0.00
heart, fetal, pool1	10046-101G1	20.95	5.44	2.77	13.14	3.70	2.05	1.33	1.85	1.03	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	112.92	33.94	8.02	2.78	12.03	6.17	2.78	0.62	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	10.70	0.00	1.19	3.57	1.19	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1.88	6.85	0.44	0.44	1.88	1.10	6.30	2.32	1.33	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	3.16	8.01	0.49	0.36	2.67	1.70	8.13	2.18	2.67	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2.02	6.27	0.61	0.30	2.63	1.21	7.58	2.32	1.92	0.40
hepatoma cell line:Li-7	10484-107A7	1.67	3.11	0.00	0.11	1.67	1.00	1.11	0.11	0.11	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	70.97	16.09	52.05	28.39	21.77	9.46	4.73	2.84	1.89	1.89
hippocampus, adult, donor10252	10153-102I9	72.86	15.31	42.86	61.64	19.80	5.31	2.65	4.29	9.59	1.22
hippocampus, adult, donor10258	10374-105G5	109.55	10.95	22.41	37.84	18.42	18.92	8.47	0.50	1.00	1.99
hippocampus, newborn, donor10223	10363-105F3	57.45	7.05	32.78	22.56	5.99	9.16	3.52	1.41	1.06	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	0.00	1.22	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.00	0.98	0.00	0.20	0.59	0.00	0.00	0.20	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	0.25	1.78	0.25	0.00	1.02	0.00	0.25	0.00	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.56	3.95	0.00	0.00	0.56	0.56	1.13	0.00	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	0.77	1.55	0.26	1.29	2.07	0.00	1.03	0.00	0.26	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.00	1.90	0.38	0.76	3.04	0.38	0.76	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.21	1.46	0.29	1.46	4.09	0.29	1.17	0.00	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.51	5.17	0.22	1.51	2.80	1.29	2.37	0.86	0.22	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1.67	3.75	0.83	2.09	4.17	0.83	2.50	0.00	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	0.47	0.95	0.71	0.00	2.13	0.24	1.18	0.47	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	0.96	3.05	0.64	0.96	2.41	0.32	1.93	0.32	0.32	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	2.02	2.02	0.67	1.35	3.37	0.67	0.67	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	0.31	0.78	0.00	0.16	0.16	0.00	0.16	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.00	0.49	0.00	0.00	0.49	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.00	0.00	0.00	0.87	0.00	0.00	0.00	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.57	4.20	0.19	0.76	4.77	0.38	0.95	0.00	0.00	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.44	1.74	0.44	0.44	8.72	0.44	1.31	0.44	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.50	1.50	0.00	1.00	3.00	0.50	1.50	0.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1.88	1.88	0.00	0.75	2.83	0.57	1.13	0.19	0.19	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.91	0.91	0.00	0.00	4.09	0.91	1.36	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.57	0.00	0.00	0.31	4.07	0.63	0.63	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	0.16	0.33	0.00	1.14	0.98	0.00	1.47	0.00	0.16	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1.45	1.74	0.29	0.29	2.03	0.00	2.03	0.00	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	0.30	0.90	0.00	0.00	1.79	0.30	3.59	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	0.55	0.92	0.18	0.00	0.55	0.55	1.11	0.18	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.00	1.14	0.00	0.29	0.29	0.29	0.57	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	0.41	2.04	0.00	0.00	0.41	0.00	1.22	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	0.00	1.41	0.35	0.35	3.52	0.00	1.76	0.70	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	0.32	0.95	0.00	1.27	2.53	0.00	0.95	0.00	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	0.61	1.82	0.00	0.00	4.24	0.91	0.61	0.00	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	0.52	2.59	0.00	0.52	3.10	0.00	1.03	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1.99	0.66	0.00	0.66	1.99	0.66	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	0.26	1.54	0.00	0.51	2.31	0.26	1.80	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	0.51	1.79	0.26	0.51	3.58	0.00	1.53	0.00	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	0.76	0.76	0.00	0.00	2.27	0.76	3.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	1.01	1.34	0.00	0.34	3.02	0.67	1.34	0.34	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.48	1.45	0.24	0.24	1.21	0.00	0.97	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.00	1.34	0.00	0.45	0.89	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.49	1.46	0.00	0.00	1.46	0.49	0.49	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.22	2.75	0.00	0.00	3.67	0.31	0.92	0.00	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.99	1.32	0.00	0.00	3.31	0.33	0.66	0.00	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.09	2.19	0.00	0.55	2.19	0.00	3.28	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	0.36	3.26	0.00	1.45	2.17	0.36	2.17	0.00	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	0.36	2.14	0.00	0.71	1.42	0.00	1.78	0.36	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1.19	0.00	0.00	1.19	0.00	0.00	0.00	0.00	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	0.81	1.49	0.14	0.81	2.17	0.54	1.35	0.14	0.27	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	0.54	1.08	0.27	0.27	2.42	0.00	0.81	0.54	0.27	0.54
immature langerhans cells, donor1	11904-125F5	21.31	5.81	10.41	0.73	4.36	1.21	5.33	4.60	1.70	0.73
immature langerhans cells, donor2	11905-125F6	9.51	5.54	6.34	0.79	5.54	0.00	2.38	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	116.30	17.79	130.03	60.09	37.29	21.01	8.33	2.08	9.18	7.10
keratoacanthoma cell line:HKA-1	10791-110H8	2.60	9.10	0.00	0.33	0.65	1.63	8.45	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	5.71	5.41	1.40	0.80	2.10	1.30	1.70	0.90	1.30	0.60
kidney, fetal, pool1	10045-101F9	4.67	5.45	1.06	1.70	5.66	2.69	2.33	0.71	0.64	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.90	3.04	0.14	0.14	0.83	0.69	0.14	0.69	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1.47	1.47	0.00	0.00	0.18	0.92	0.73	0.37	0.00	0.00
left atrium, adult, donor1	10079-102A7	15.26	4.90	1.63	6.54	2.72	0.00	1.63	1.63	1.63	0.54
left ventricle, adult, donor1	10078-102A6	9.10	6.07	3.54	1.52	0.51	0.51	2.02	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.78	45.42	0.55	6.02	10.94	0.55	0.82	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	13.65	3.95	1.08	0.00	0.72	1.08	2.16	0.36	2.16	0.72
leiomyoma cell line:15242A	10570-108B3	8.15	4.89	1.09	1.63	1.63	2.72	0.54	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	23.55	7.28	1.21	0.97	1.70	1.94	1.21	0.49	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	12.70	12.70	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	21.96	2.09	0.00	4.18	3.14	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.71	0.83	0.12	0.00	0.00	0.12	0.12	0.00	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	16.09	7.65	0.16	1.87	2.19	1.41	0.31	0.94	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	8.41	12.43	0.12	1.34	2.07	1.34	1.71	0.24	0.00	0.97
liver, adult, pool1	10018-101C9	4.54	5.19	0.65	2.43	2.27	0.81	6.00	4.86	2.27	0.65
liver, fetal, pool1	10086-102B5	0.00	3.76	0.94	0.94	2.82	0.94	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	59.93	11.52	2.62	11.52	9.62	3.06	1.90	1.90	1.02	0.15
locus coeruleus, adult, donor10252	10165-103B3	47.24	11.44	5.17	23.62	11.81	2.77	3.32	2.77	4.43	0.55
locus coeruleus, adult, donor10258	10375-105G6	64.33	9.87	5.64	21.44	15.52	3.39	4.80	1.41	0.85	0.85
locus coeruleus, newborn, donor10223	10362-105F2	39.96	4.63	7.57	12.62	7.15	2.10	0.84	1.26	3.36	1.68
lung adenocarcinoma cell line:A549	10499-107C4	3.32	4.84	0.69	0.28	0.69	1.25	0.55	0.42	0.00	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	1.38	1.38	0.00	0.00	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	17.60	5.79	4.61	0.83	2.24	1.06	1.65	2.84	0.95	0.71
lung, fetal, donor1	10068-101I5	7.14	4.28	2.28	1.14	1.71	0.57	0.00	1.43	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	9.62	16.95	8.71	5.50	7.79	1.37	1.37	3.21	0.46	0.46
lymph node, adult, donor1	10077-102A5	14.67	15.15	5.68	0.95	1.89	0.95	3.31	4.73	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3.47	2.72	0.30	0.45	4.38	3.02	1.51	0.00	0.30	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1.70	2.55	0.00	0.85	0.00	0.00	0.85	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	7.55	4.88	0.44	4.88	0.44	0.89	2.22	2.22	0.00	0.00
mature adipocyte, donor2	12232-129F9	14.32	4.57	0.42	2.28	1.66	1.25	2.49	2.70	0.21	0.00
mature adipocyte, donor3	12233-129G1	5.69	5.22	0.47	2.84	0.71	2.37	0.71	1.19	0.00	0.00
mature adipocyte, donor4	12234-129G2	4.21	3.95	0.79	0.53	0.26	1.32	1.05	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.24	0.48	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	108.29	19.18	69.94	30.46	24.82	16.92	3.38	2.26	4.51	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	93.24	23.54	48.92	56.46	22.80	16.37	7.17	4.23	9.01	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	96.26	17.16	42.57	46.70	28.59	16.84	8.26	0.95	2.22	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	25.59	2.56	66.11	10.24	11.94	2.99	0.85	0.85	4.69	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	109.18	16.03	97.20	50.46	27.17	17.38	5.23	1.35	21.77	3.88
medial temporal gyrus, adult, donor10252	10156-103A3	88.50	23.13	54.97	55.60	25.68	9.97	5.73	3.82	7.64	2.55
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	92.46	3.85	25.04	28.89	17.34	23.12	5.78	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	100.48	28.71	43.06	43.06	0.00	0.00	71.77	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	55.63	6.46	100.50	16.51	18.66	3.23	2.15	1.44	1.79	4.67
medulla oblongata - adult, donor10196	10174-103C3	42.18	5.19	1.30	9.09	7.79	3.24	1.95	1.95	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	52.63	12.54	7.43	25.85	10.68	3.10	2.17	4.33	6.04	0.93
medulla oblongata, adult, pool1	10038-101F2	59.67	8.49	2.86	22.20	8.65	3.92	3.84	2.29	2.29	0.82
medulla oblongata, newborn, donor10223	10361-105F1	54.16	5.90	3.82	12.85	7.99	3.82	2.08	1.74	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	30.94	13.08	0.12	0.49	1.10	1.83	1.96	1.10	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	44.99	28.46	11.07	5.17	23.00	3.88	3.59	1.15	2.44	4.17
melanoma cell line:G-361	10465-106H6	39.90	17.92	4.89	5.70	12.76	2.44	2.71	0.00	2.99	2.99
meningioma cell line:HKBMM	10691-109F7	0.72	1.27	0.00	0.00	0.00	0.72	0.18	0.18	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.88	7.05	0.00	2.64	0.88	0.88	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	2.33	3.11	0.00	0.26	0.26	0.52	1.04	0.00	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.67	6.44	1.07	1.69	1.84	0.46	0.61	0.15	0.61	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.54	7.27	1.64	2.54	3.64	0.91	1.09	0.36	1.27	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	3.31	0.83	0.83	0.83	3.31	2.07	0.83	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.45	3.93	1.26	0.42	0.14	1.97	0.84	0.56	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.24	2.12	1.16	0.77	0.77	0.58	0.19	0.39	0.77	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	3.47	1.39	0.69	0.69	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.19	5.15	0.86	0.17	1.03	1.37	1.72	0.86	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.79	5.41	1.50	1.84	2.99	1.96	0.92	0.46	0.69	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.93	4.24	0.93	0.80	1.19	1.46	0.40	1.46	0.80	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	28.76	7.70	2.70	1.35	2.30	1.35	1.49	2.16	2.16	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.23	4.69	0.43	0.43	0.71	2.85	1.14	0.57	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.37	8.89	1.32	0.99	3.62	4.28	3.29	1.65	1.32	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.87	6.64	2.77	0.69	1.80	3.04	0.55	0.69	0.42	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	6.63	3.14	0.00	0.00	0.00	1.40	1.05	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.96	3.67	0.41	0.41	1.02	2.45	0.41	0.41	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	5.03	0.72	0.36	3.59	1.44	0.72	0.00	1.44	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	37.35	10.76	2.48	1.66	3.10	3.52	0.72	0.83	1.24	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.01	5.24	1.14	1.37	2.96	1.60	0.68	0.91	0.46	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.20	6.71	0.42	1.26	1.26	3.36	0.42	0.42	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	5.53	3.29	0.30	0.15	0.75	1.49	1.20	1.20	1.05	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.78	5.51	1.40	0.61	1.58	2.19	0.53	0.61	1.40	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	36.82	7.36	2.95	1.10	2.58	3.31	0.37	0.74	2.58	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.31	4.86	2.00	2.29	1.43	3.72	1.43	0.29	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	78.73	18.95	1.26	3.37	9.68	0.84	3.37	0.42	2.95	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	3.20	1.37	2.74	2.74	0.91	0.00	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	4.86	0.51	1.02	2.05	1.02	1.28	0.51	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.56	6.28	1.31	0.52	2.88	1.57	0.52	0.00	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.56	5.55	0.62	2.46	1.85	0.62	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.24	3.77	0.71	2.35	2.35	1.18	0.24	0.24	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.46	7.11	0.68	2.03	2.71	0.00	1.35	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.40	7.07	0.79	1.57	1.57	1.18	1.18	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	5.56	2.32	1.39	0.93	0.93	2.32	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	4.33	1.44	2.88	3.46	1.73	1.15	0.87	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.39	4.24	0.89	3.12	3.79	0.45	1.78	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	6.01	0.72	2.88	2.16	1.20	1.20	0.48	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	4.40	1.47	0.73	2.93	1.47	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	3.69	1.01	2.69	1.68	1.34	1.01	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	5.73	0.82	0.82	2.46	0.41	0.00	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.32	8.16	0.43	2.58	3.87	1.72	1.72	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	0.00	5.47	2.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.54	4.55	0.97	4.55	1.62	0.65	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	5.82	1.45	2.91	0.00	1.45	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	8.00	0.00	2.13	2.13	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	3.27	0.00	0.82	1.64	1.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.66	4.28	0.00	3.89	1.55	0.78	0.78	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	6.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	5.96	0.99	3.97	2.98	0.99	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	7.12	0.00	2.37	2.37	0.59	0.00	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	3.66	0.00	2.44	1.22	0.00	3.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	3.80	1.27	1.90	2.53	0.00	1.27	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.55	2.07	0.00	0.69	0.34	0.00	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	4.30	0.00	4.30	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	3.99	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	0.00	6.89	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	3.26	0.81	0.00	0.81	0.41	0.41	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	3.18	0.79	3.97	0.79	0.79	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1.77	0.00	0.59	1.18	0.00	0.59	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	1.87	0.00	2.49	0.00	0.31	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	0.00	0.00	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	1.18	0.00	3.55	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1.38	0.00	0.00	0.69	0.69	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.99	0.49	0.00	0.00	0.00	0.49	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	0.00	4.45	0.00	1.91	0.64	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.40	0.81	0.00	0.40	0.40	0.00	0.40	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	0.00	0.00	0.00	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1.21	4.25	0.00	3.03	2.43	0.61	0.61	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	4.52	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.00	4.12	0.00	3.29	0.82	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	2.78	3.37	0.00	2.98	0.60	0.20	0.40	0.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.30	2.60	0.32	1.30	0.65	1.30	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	0.00	1.02	0.00	1.02	1.02	1.02	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1.42	2.13	0.24	0.00	0.47	0.47	0.24	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	5.33	5.79	2.09	0.23	4.40	2.09	2.09	0.46	1.16	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	4.27	0.00	0.00	0.00	4.27	0.00	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	3.90	1.75	0.51	0.62	0.72	0.82	1.03	0.31	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	0.68	0.68	0.00	0.00	0.91	0.00	0.45	0.00	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	10.76	9.53	1.22	0.98	3.18	1.71	1.71	0.98	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	1.77	1.99	0.66	0.44	0.22	0.00	0.22	0.66	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	0.26	1.84	0.00	0.00	0.79	0.00	0.00	0.00	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	5.96	3.40	0.51	1.02	1.53	0.51	1.02	0.17	0.68	0.51
mesothelioma cell line:Mero-84	10855-111F9	11.12	10.62	1.01	0.76	1.77	0.25	1.26	0.25	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	14.91	8.70	2.28	2.28	4.55	2.07	2.07	2.28	0.83	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	27.00	10.60	1.33	1.82	2.15	1.82	1.99	0.66	2.48	0.99
mesothelioma cell line:NCI-H226	10846-111E9	4.34	6.33	0.00	0.18	1.09	1.27	0.72	0.36	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	13.84	11.10	1.88	1.20	2.39	2.05	0.34	0.17	0.85	0.34
mesothelioma cell line:NCI-H28	10845-111E8	26.21	19.59	1.53	4.83	5.60	5.09	1.53	0.00	1.27	0.76
mesothelioma cell line:No36	10857-111G2	0.98	2.94	0.00	0.33	2.28	1.30	1.63	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	0.00	0.54	0.00	0.00	0.27	0.27	0.00	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	10.75	11.32	6.53	0.77	3.65	0.96	1.54	0.96	0.77	0.96
migratory langerhans cells, donor2	11902-125F3	10.14	16.97	5.62	0.37	3.05	2.93	2.20	1.47	0.61	0.37
migratory langerhans cells, donor3	11903-125F4	24.23	25.49	8.79	0.54	3.59	2.87	1.44	2.33	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	1.31	0.98	0.33	0.33	1.96	0.65	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	1.06	0.42	0.00	0.00	0.00	0.00	0.21	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.30	4.84	0.92	0.00	0.46	1.84	0.92	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	18.29	9.79	15.89	0.37	1.66	1.85	0.37	0.37	0.92	1.29
myeloma cell line:PCM6	10474-106I6	0.40	0.59	0.00	0.00	0.20	0.59	0.20	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.91	11.57	0.39	0.59	0.78	4.32	1.37	0.00	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2.56	1.89	0.45	0.22	0.56	0.89	1.11	0.33	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.43	1.76	0.15	0.00	0.88	0.44	0.44	0.51	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	8.28	4.97	1.66	0.55	3.31	1.10	2.76	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.46	1.15	0.46	0.46	0.23	0.00	0.23	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.19	0.00	0.19	0.56	0.19	0.00	0.00	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	50.61	31.00	1.27	11.39	8.86	2.11	4.01	0.00	1.48	1.69
neuroblastoma cell line:NH-12	10555-107I6	0.00	0.00	0.00	0.19	0.00	0.37	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.97	16.61	7.12	14.71	4.27	2.14	2.37	0.24	2.85	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.95	10.45	2.38	9.19	4.43	1.90	2.69	0.79	1.27	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	1.21	0.81	0.20	1.41	0.20	0.00	0.40	0.20	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.26	33.70	1.91	1.91	1.27	1.27	1.91	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	20.49	18.63	1.86	3.19	3.73	0.53	1.06	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	74.37	178.50	29.75	0.00	0.00	59.50	104.12	74.37	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	13.28	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00	0.00	0.00	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1.92	2.89	0.00	0.32	1.60	0.32	0.32	0.32	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.04	1.84	0.79	0.79	2.10	0.53	0.53	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	92.61	15.00	62.24	45.65	21.75	17.44	4.87	2.16	6.47	2.81
occipital cortex - adult, donor10196	10172-103C1	119.50	18.54	72.11	30.91	35.03	18.54	8.24	0.00	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	96.34	26.03	33.28	48.57	23.62	12.34	4.56	1.88	9.93	1.88
occipital cortex, newborn, donor10223	10355-105E4	81.89	8.01	103.72	20.38	15.29	6.91	2.18	0.73	2.55	1.82
occipital lobe, adult, donor1	10076-102A4	147.99	27.55	78.46	69.80	28.60	14.69	7.61	3.41	4.20	7.35
occipital lobe, fetal, donor1	10073-102A1	5.58	4.29	1.29	7.72	2.15	3.00	1.29	0.00	0.86	0.43
occipital pole, adult, pool1	10036-101E9	145.94	17.03	54.32	61.81	27.59	22.63	8.99	2.13	4.81	3.15
olfactory region, adult	10195-103E6	110.62	18.15	67.44	50.06	22.74	12.99	6.11	1.15	5.16	3.06
optic nerve, donor1	10277-104E7	52.03	8.00	0.00	16.01	6.00	2.00	6.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.10	1.71	0.00	0.34	0.46	0.68	5.01	0.68	0.68	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1.79	3.85	0.00	0.14	1.10	1.10	1.37	0.14	0.14	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.08	1.19	0.17	0.17	1.19	0.85	3.05	0.00	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.19	5.89	0.69	0.81	3.00	1.62	1.39	0.12	0.35	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	14.70	7.64	0.00	0.59	1.76	1.47	2.35	0.88	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	5.61	0.00	0.00	0.93	0.00	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	0.00	0.21	0.00	0.42	0.21	0.00	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	10.57	3.84	1.75	4.80	2.53	0.96	1.75	1.57	1.14	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.51	11.37	0.37	0.92	2.20	2.93	0.55	1.10	0.00	0.55
pancreas, adult, donor1	10049-101G4	2.82	5.64	0.00	4.70	0.00	0.00	1.88	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	7.67	7.67	0.34	0.85	2.73	1.19	3.07	1.70	1.70	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	2.32	1.66	0.17	0.17	0.99	0.66	0.50	0.17	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	108.55	16.75	61.41	51.98	25.08	20.04	7.50	1.56	4.85	3.94
parietal cortex, adult, donor10258	10373-105G4	51.38	8.07	44.77	38.17	17.62	12.48	5.87	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	84.64	13.17	49.85	30.10	12.23	14.11	0.94	0.00	4.70	3.76
parietal lobe, adult, donor10252	10157-103A4	89.22	21.09	52.16	50.74	22.80	11.12	6.56	1.14	9.12	2.85
parietal lobe, adult, pool1	10034-101E7	112.09	17.89	62.21	53.05	28.55	19.21	8.11	1.50	6.96	3.26
parietal lobe, fetal, donor1	10072-101I9	6.79	3.88	0.00	7.76	2.91	0.97	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	63.93	4.49	99.07	19.81	19.81	4.11	2.62	1.12	4.11	2.99
parotid gland, adult	10199-103F1	4.93	5.55	2.47	3.08	1.85	3.08	3.70	1.85	0.62	0.00
penis, adult	10200-103F2	8.06	4.30	0.00	2.69	1.61	1.07	1.07	0.54	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	49.46	35.89	2.79	34.77	10.41	2.97	1.30	0.56	2.79	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	2.48	3.06	0.15	0.73	1.60	0.44	2.77	0.87	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	8.39	8.39	3.23	2.58	1.29	4.52	1.94	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	7.11	3.55	2.37	1.78	4.15	3.55	0.00	1.78	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	21.32	2.51	1.88	3.14	2.51	1.88	3.14	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	12.14	1.01	1.01	5.06	2.02	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	9.90	6.78	3.13	4.17	2.08	4.17	0.00	1.04	2.61	0.00
pituitary gland, adult, donor10258	10378-105G9	6.81	0.85	3.40	2.55	0.85	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	3.44	4.95	2.15	0.65	1.08	1.29	4.19	0.54	0.43	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	3.58	2.12	0.93	0.00	0.53	1.06	0.53	0.00	1.06	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	9.18	4.98	0.16	0.93	0.93	1.87	0.16	0.00	0.16	0.16
pons, adult, pool1	10033-101E6	36.41	6.71	3.61	15.75	7.23	6.20	3.27	2.15	1.89	0.60
postcentral gyrus, adult, pool1	10032-101E5	124.92	12.73	75.58	60.67	27.46	19.35	7.76	1.92	6.54	3.14
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	56.47	20.91	2.09	6.27	8.37	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	0.00	0.00	5.51	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	2.91	2.91	0.00	0.15	0.15	0.58	0.29	0.00	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	21.78	11.43	0.00	0.18	1.63	1.27	1.09	1.09	0.91	0.18
prostate, adult, pool1	10022-101D4	6.98	4.81	1.54	2.27	1.09	1.36	1.00	1.00	0.63	0.00
putamen, adult, donor10196	10176-103C5	55.95	7.32	74.60	28.56	10.39	12.75	2.83	1.89	5.67	0.71
putamen, adult, donor10252	10152-102I8	62.74	3.92	23.53	25.49	3.92	1.96	5.88	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	2.19	7.65	5.46	4.37	9.84	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.73	6.28	39.38	25.85	11.36	9.66	0.48	0.00	4.11	0.72
putamen, newborn, donor10223	10365-105F5	11.99	6.75	38.23	9.75	9.75	1.50	0.00	0.75	2.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	2.04	2.04	0.00	0.29	0.58	0.29	1.75	0.00	0.29	0.29
rectum, fetal, donor1	10067-101I4	26.43	12.52	1.39	9.74	4.17	0.00	1.39	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	258.00	75.47	2.76	7.63	17.38	9.33	3.60	0.64	5.30	2.33
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	93.61	15.74	0.00	0.83	2.90	0.83	0.83	0.00	2.90	0.83
retina, adult, pool1	10030-101E3	30.91	13.12	2.19	9.84	6.56	4.08	3.88	1.59	1.59	1.09
retinoblastoma cell line:Y79	10475-106I7	0.78	5.46	0.00	0.78	1.30	1.56	0.26	0.00	0.26	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	0.84	1.97	0.00	0.56	1.69	0.00	0.00	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	23.49	17.43	0.76	2.27	4.55	0.00	0.76	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	14.89	5.34	0.97	2.59	3.08	2.27	5.34	0.49	0.81	0.32
salivary acinar cells, donor2	11772-123I8	17.21	6.47	0.41	3.58	3.30	3.03	8.26	1.10	1.65	0.83
salivary acinar cells, donor3	11773-123I9	19.20	9.93	0.00	5.96	2.65	1.99	8.61	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	15.44	8.01	1.72	5.15	1.14	4.58	6.86	2.86	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	0.59	0.17	0.00	0.17	0.08	0.17	0.08	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	0.59	0.59	0.00	0.00	0.00	0.00	0.24	0.12	0.00	0.00
seminal vesicle, adult	10201-103F3	9.52	8.99	2.65	2.65	3.70	4.76	2.12	0.53	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	2.43	5.83	0.24	0.97	2.92	0.49	1.46	0.24	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.00	1.76	0.00	0.25	0.50	0.50	0.00	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	2.01	0.00	0.00	1.00	0.00	1.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1.21	2.01	0.00	0.13	1.07	0.81	1.48	0.94	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	1.22	0.77	0.00	0.22	0.22	0.22	0.66	0.00	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.77	3.10	0.00	0.00	1.29	0.52	1.03	0.00	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	0.00	0.00	0.00	0.00	0.71	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	6.72	3.12	2.40	2.52	1.08	0.72	2.04	0.84	0.84	0.00
skeletal muscle, fetal, donor1	10066-101I3	7.04	10.05	2.01	9.05	4.02	2.01	2.01	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	13.57	6.79	0.00	0.00	13.57	6.79	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	6.94	6.31	0.00	3.16	1.89	3.79	1.26	0.00	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	13.87	21.43	0.00	10.72	14.18	3.78	5.99	0.95	2.21	3.15
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.58	1.35	0.00	0.00	0.96	0.58	0.19	0.39	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	4.42	4.66	2.03	1.07	2.27	1.79	2.39	0.84	0.36	0.00
small intestine, fetal, donor1	10064-101I1	5.90	7.13	1.23	2.46	2.21	1.23	2.95	1.47	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	5.69	4.39	0.00	1.55	0.78	1.55	0.00	1.03	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	1.61	5.36	0.00	0.00	0.00	2.14	0.80	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	58.73	10.78	3.67	15.37	7.57	3.21	2.98	4.36	2.06	0.23
spinal cord, adult, donor10252	10159-103A6	60.32	10.25	7.10	21.68	8.28	3.55	3.15	5.52	4.34	1.97
spinal cord, adult, donor10258	10369-105F9	39.43	4.84	4.15	19.37	4.84	2.08	4.15	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	21.95	15.86	1.83	9.15	6.10	2.44	1.22	1.83	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	23.88	2.30	2.30	6.43	2.30	2.76	1.38	1.38	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	60.64	23.30	2.84	2.24	6.27	1.49	1.34	1.05	0.30	0.30
spleen, adult, pool1	10025-101D7	6.28	3.74	4.30	0.11	0.66	1.32	0.55	2.31	1.10	0.00
spleen, fetal, pool1	10044-101F8	6.28	4.53	3.81	0.16	1.43	0.64	0.95	1.67	1.03	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.46	10.77	7.14	0.31	4.24	2.48	1.86	0.62	1.66	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.04	1.71	0.00	0.19	0.76	0.00	1.14	0.00	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	2.45	1.40	0.35	1.40	0.35	0.00	1.05	0.70	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.77	4.30	0.00	0.00	0.39	4.69	1.95	0.39	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.68	0.45	0.00	0.34	0.45	0.34	0.00	0.23	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1.69	3.81	0.85	0.42	0.00	0.00	0.42	0.85	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	12.27	0.85	0.00	1.69	0.42	0.85	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	4.27	8.54	1.07	0.00	1.07	1.07	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	14.81	6.27	2.85	5.13	1.14	4.56	2.85	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	54.27	54.27	54.27	0.00	54.27	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	44.24	8.10	6.85	21.81	7.06	1.25	3.74	4.36	3.74	0.42
substantia nigra, adult, donor10258	10371-105G2	68.79	13.97	2.59	23.28	9.31	7.76	3.62	1.03	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	48.05	5.65	3.53	7.07	6.36	0.71	4.24	2.83	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.29	1.38	0.23	0.69	0.69	0.69	0.23	0.00	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	120.29	19.92	107.15	64.43	35.09	21.19	8.99	2.63	6.53	4.83
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	7.12	2.14	6.41	4.27	1.42	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.91	3.08	3.52	7.47	1.32	0.44	1.76	0.00	0.44	0.44
tenocyte, donor1	11763-123H8	36.66	15.71	1.75	4.89	1.75	1.40	1.75	1.40	3.49	0.35
tenocyte, donor2	11765-123I1	30.14	11.45	0.76	3.43	1.53	3.43	1.91	2.29	1.14	0.38
tenocyte, donor3	11768-123I4	13.71	7.78	1.48	0.74	2.59	3.34	0.74	0.37	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	0.34	0.51	0.34	0.00	0.00	0.17	0.00	0.00	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	0.00	0.00	0.00	0.00	0.15	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	0.00	0.31	0.00	0.00	0.00	0.15	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	0.00	0.76	0.00	0.13	0.13	0.13	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.00	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.22	0.22	0.00	0.00	0.33	0.11	0.33	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.00	0.33	0.33	0.65	0.00	0.00	0.33	0.00	0.00	0.33
testis, adult, pool1	10026-101D8	7.62	3.33	1.72	1.07	1.93	1.29	0.64	1.07	1.07	0.64
testis, adult, pool2	10096-102C6	4.06	3.61	0.45	0.00	2.71	3.61	0.45	0.45	0.90	0.90
thalamus - adult, donor10196	10168-103B6	60.72	9.94	5.52	30.91	11.04	3.31	5.52	5.52	1.10	0.00
thalamus, adult, donor10252	10154-103A1	64.86	17.19	13.13	33.76	11.72	3.91	2.66	4.84	6.72	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	135.49	9.24	3.08	29.25	10.78	10.78	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	73.12	19.10	11.53	23.39	13.50	4.61	5.11	3.29	0.99	1.81
thalamus, newborn, donor10223	10366-105F6	24.16	6.90	22.44	9.21	23.01	2.88	4.03	1.15	0.00	4.60
throat, adult	10209-103G2	4.74	2.75	0.25	1.75	2.00	1.00	1.50	0.75	0.75	0.00
throat, fetal, donor1	10061-101H7	8.53	6.70	2.13	3.05	1.83	1.52	1.22	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	1.39	0.79	0.20	2.58	0.40	0.20	0.60	0.00	0.40	0.60
thymus, adult, pool1	10027-101D9	2.58	2.49	1.39	0.20	0.40	0.40	0.30	0.60	0.10	0.40
thymus, fetal, pool1	10043-101F7	3.22	1.77	1.66	0.21	0.42	0.42	0.62	0.42	0.42	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.50	7.98	1.20	0.40	1.60	1.20	0.40	0.80	2.79	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	41.49	30.59	0.28	3.49	7.12	5.17	6.15	3.77	2.10	1.96
thyroid, adult, pool1	10028-101E1	3.08	3.83	1.12	0.93	0.93	0.47	1.31	1.31	1.03	0.19
thyroid, fetal, donor1	10060-101H6	3.95	9.23	0.79	2.11	3.16	1.05	0.79	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	12.32	0.00	0.00	6.16	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	4.19	1.63	1.40	1.40	0.70	0.23	2.56	0.47	0.70	0.00
tongue, fetal, donor1	10059-101H5	6.31	5.52	0.00	0.39	1.18	0.79	0.79	0.39	0.79	0.79
tonsil, adult, pool1	10047-101G2	5.41	4.11	2.10	1.50	1.10	1.60	2.50	0.50	1.10	0.10
trachea, adult, pool1	10029-101E2	18.98	8.43	3.76	2.45	3.60	1.72	3.19	2.13	1.64	0.33
trachea, fetal, donor1	10058-101H4	19.62	3.85	1.54	1.92	5.77	1.54	0.38	1.54	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	11.69	8.15	0.71	1.06	1.77	0.71	0.35	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	8.21	3.04	0.00	0.41	1.42	0.51	1.11	0.20	0.10	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	38.05	20.93	0.00	0.00	1.90	3.81	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1.02	2.88	0.00	0.00	0.51	0.00	0.17	0.34	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	6.26	4.17	2.09	0.00	2.09	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	6.14	4.61	2.22	1.54	1.19	1.88	0.68	0.34	0.34	0.17
uterus, fetal, donor1	10055-101H1	4.61	6.66	2.05	1.54	0.51	0.51	2.05	1.02	0.00	0.51
vagina, adult	10204-103F6	10.99	8.40	1.94	1.94	1.94	1.94	2.58	3.23	0.65	0.00
vein, adult	10191-103E2	7.67	7.23	3.51	1.75	2.19	1.75	1.10	2.19	1.10	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.21	3.20	1.34	0.00	0.53	1.07	0.53	0.00	0.00	0.80